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ABSTRACT 
 
PROTEOMIC ANALYSIS OF THE EFFECT OF METABOLIC ACIDOSIS ON THE 
APICAL MEMBRANE OF THE RENAL  PROXIMAL CONVOLUTED TUBULE 
 
 Metabolic acidosis is a physiological disturbance which results in a decrease in 
blood and extracellular pH and HCO3
-
.   The renal response to this disturbance is initiated 
in the proximal convoluted tubule (PCT) of the kidney. At the PCT, the brush border 
membrane facilitates solute reabsorbtion and excretion of acid during acidosis.  However, 
the extent of the global remodeling of proteins at the brush border remains mostly 
unknown. Therefore a proteomic investigation of the remodeling of theseproteins during 
metabolic acidosis at the brush border was completed.  First, using LTQ mass 
spectrometry and spectral counting, an enrichment method was tested that analyzed brush 
border membrane vesicles (BBMV) from cortex versus those which were derived from 
purified proximal convoluted tubules.  From these  results we detected and hypothesized 
that enzymes of glucose metabolism localized at the brush border would be altered in 
abundance during acidosis at the PCT brush border. Next, we performed a quantitative 
analysis of the temporal response to metabolic acidosis during 1-d, 3-d and 7-d acidosis 
using Q-TOF mass spectrometry and spectral counting.  As expected, the results 
indicated a decrease of enzymes of glucose metabolism including Fructose-1,6-
iii 
 
bisphosphatase 1 and Enolase A.  Aldolase A was found to be transiently decreased 
during 1-d and 3-d acidosis.  In addition, the Na
+
-glucose transporter 2 was found to be 
transiently increased during 1-d and 3-d acidosis.  Finally, to confirm these abundance 
changes detected using spectral counting, an accurate mass and time tag method was 
developed.  Using this method, we successfully developed an AMT database of the 
previously identified  spectra.  This database was used to match peptides detected using 
QTOF-LC-MS to the previously identified peptides. Peptide abundance by spectral 
counting was validated using the more accurate peak intensities and were generally in 
concordance with those abundance measurements using spectral counting.   The 
developed model suggested a mechanism for internalization of these enzymes of glucose 
metabolism  in  support of glutamine metabolism, which is central to the cellular 
response to acidosis by the PCT. 
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CHAPTER 1 
Introduction 
 
1.1  Introduction and Historical Background 
Metabolic acidosis is a physiological disturbance which results in a decrease in 
blood and extracellular pH and HCO3
-
.   The renal response to this disturbance is initiated 
in the proximal convoluted tubule (PCT) of the kidney.  The PCT cell is the primary site 
of NH4
+
 and HCO3
-
 ion sythesis that contributes to the maintenance of blood pH during 
the onset of acidosis.    Current techniques and methodologies can give exciting and new 
insight into the molecular mechanisms that regulate this response.  However, basic 
research into the understanding of the mechanisms of acid-base homeostasis extends over 
a century.  In 1902, Barcroft first described a method to measure carbonic acid, H3CO3, 
in blood[1].  However, it was Hasselbalch who first described the relationship of the 
levels of CO2 in blood with pH leading to the well known Henderson-Hasselbalch 
equation and it's application to the determination of blood pH [2].  In 1923, La Mer 
described the measurement of CO2 as a direct measurement of pH[2].  These landmark 
experiments, among others, lead to the suggestion that the rapid dissociation of carbonic 
acid contributed to buffering of blood pH.   Ammonium ions, which provide a measure of 
the acid excreted during metabolic acidosis, was first measured with precision using the 
Folin-Denis method[3].  Using this method, Nash and Barcroft, in 1921, described that 
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the kidney produces the ammonium ions it excretes.  In 1943, Van Slyke observed in 
dogs that GLN extracted from  blood could account for 60% of the total ammonium 
excreted by the kidneys during acidosis[4].  Later observations by Kennan et al. 
suggested that increases in the concentrations of glutamine (GLN) in blood occur in 
diabetic ketoacidosis [5].  Kennan realized that glutamine concentration increased as 
acidosis increased.  As such, these observations linked the production of GLN with a 
decrease in blood pH.   However, it was an 
15
N metabolic tracer experiment that 
definitively linked GLN synthesis in the liver with GLN catabolism and ammonium 
production in the kidney during chronic metabolic acidosis [6].  Later, it was Goorno who 
suggested that gluconeogenesis was a metabolic pathway that was stimulated concurrent 
with ammonium production[7, 8].  Later studies elucidated the interorgan relationship for 
controlling blood ammonia levels  through GLN production and established accurate 
blood and urinary measurements for metabolic intermediates for the response to 
acidemia[9, 10].  Physiological and anatomical studies and their measurements of filtrate 
and blood aided in the determination of the response along the nephron of the kidney 
[11].   These experiments subsequently determined the significance of renal proximal 
tubular contribution to acid-base regulation.   Elucidation of the mechanisims for 
transcriptional activation of phosphoenolpyruvate carboxykinase 1 (PCK1) and 
mitochondrial glutaminase followed.  In these experiments, activation of p38 mitogen 
activating protein kinase (MAPK) during onset of acidosis induced PEPCK 
expression[12, 13]. More recently, selective stabilization of PCK1 and mitochondrial 
glutaminase mRNAs were shown to contribute to the renal response to acidosis[14-18].  
Taken together, these many years of experiments outlined how glutamine catabolism is 
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related to the excretion of ammonia and the production and reabsorbtion of bicarbonate in 
response to acidosis.  However many of the regulatory, metabolite and pH sensing, and 
signal transduction mechanisms remain to be elucidated. 
 
1.2 Definition and causes of metabolic acidosis 
 Metabolic acidosis is a physiological disturbance which results in a decrease in 
blood and extracellular pH and HCO3
-
.  The condition is caused by a decrease of 
available bicarbonate (HCO3
-
), the primary buffer in blood, or an increase in acid[19].  
Bicarbonate and the partial pressure of dissolved arterial CO2 (pCO2) tightly regulate 
blood pH.   Metabolic acidosis is also characterized with a decrease in hepatic urea 
production and an increase in renal ammonium ion production[20].  Additionally, 
increased glutamine (GLN) synthesis in both perivenous hepatocytes and in skeletal 
muscle tissue lead to an increase in blood GLN concentration [9, 21]. The proximal 
tubule cell in kidney responds to the increase in blood concentration of glutamine by 
activating the catabolism of glutamine. 
 Generally, physiological disturbances which cause a significant decrease in 
plasma pH and blood are called acidemia.   Those disturbances which are metabolic in 
origin are called metabolic acidosis (MA).  Physiological disturbances which can cause 
MA include diabetes, chronic obstructive pulmonary disorder, cancer, alcoholism, 
starvation, digestive abnormalities (diarrhea) and genetic disorders such as the renal 
Fanconi syndrome. These disturbances are ubiquitously characterized by decreased blood 
pH (pH < 7.35) and by a decrease in bicarbonate buffering capacity. However, the 
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mechanism by which metabolic acidosis progresses is as varied as the primary 
disturbance causing MA.  These include: 
1) Loss of bicarbonate due to diarrhea and other conditions that cause rapid 
water loss 
2) Increased use of bicarbonate due to buffering of increased organic acids in the 
blood due to lactic acidosis (cancer) or ketoacidosis (diabetes, cancer, chronic 
obstructive pulmonary disorder, starvation) 
3) Loss of renal capacity to reabsorb bicarbonate (renal Fanconi syndrome) 
As such, the primary disturbance can typically be determined by profiling of 
urinary and blood solutes.  Electrolytes in blood (Na
+
, K
+
, HCO3
-
, Cl
-
) help to determine 
the underlying cause of MA.  This can determine if the MA is caused by bicarbonate 
buffering of organic acids leading to an increased anion gap, which is typical of those 
conditions where acid production increase.  Alternatively, these measurements can also 
determine if the MA is due to a loss of bicarbonate ions, such as is typical in patients with 
chronic diarrhea.    
 
1.3 Glutamine and renal metabolism during normal physiology 
Glutamine serves as a primary carrier for nitrogen transport between the organs.  
It’s high abundance (0.5 - 1.0mM) in blood together with it’s high relative abundance in 
the tissues other than kidney ensure a readily releasable pool for use during stress[21].     
As a metabolite, GLN is consumed as a fuel in liver, the digestive tract, and brain.   
Production of GLN occurs by the ATP-dependent glutamine synthetase, an enzyme 
highly enriched in perivenous hepatocytes and skeletal muscle[22].  Glutamine 
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catabolism supports additional metabolic processes such as ureagenesis and 
gluconeogenesis in periportal hepatocytes and ammoniagenesis and gluconeogenesis in 
the kidney.   
During normal physiology, GLN enters the filtrate and is extracted from the 
lumen of the nephron but very little is catabolized by the kidney[21].  The apical B
o
AT1 
transporter aids the Na
+
-dependent facilitated transport into the PCT, followed by the 
basolateral transport of GLN by the system L type heteromeric transporter, LAT2[23, 
24].  Additionally, a small proportion of the recovered GLN (~10%) is catabolised by the 
PCT in a mechanism central to acid-base maintenance.  Specifically, GLN enters the 
mitochondria by an unidentified transporter and is subsequently deamidated by 
mitochondrial glutaminase (GA) to glutamate.  Subsequent deamination by glutamate 
dehydrogenase produces α−ketogluterate, which then enters the citric acid cycle.   These 
deamidation steps result in the production of two NH4
+
 ions which are eventually 
excreted in the urine.   
 
1.4 Glutamine catabolism during acidosis 
       PEPCK is a rate limiting step required for the entrance of phosphoenolpyruvate into 
the gluconeogenic pathway.  Immunohistochemistry has shown PEPCK to be highly 
expressed in liver, intestinal enterocytes, and the PCT of the kidney[25].  Treatment of 
porcine PCT cells with acidotic medium leads to PCK1 gene activation possibly by the 
activation of p38 mitogen activated protein kinase (MAPK) signaling pathway[12].  
While PEPCK controls the rate of entrance into gluconegensis, fructose-1,6 
bisphosphatase 1 (FBP1) is also a rate limiting step in the pathway.  Porcine kidney LLC-
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PK1 cells lack endogenous FBP1 and the ability to produce glucose. Selection of cells by 
glucose starvation produced a line of cells that express FBP1 and are gluconeogenic [26, 
27].   In mammals, enzyme activity assays have determined that PEPCK and FBP1 are 
highly enriched in the PCT when compared to the more distal portions of the nephron[28, 
29].  As such, FBP1 and PEPCK are important regulators of gluconeogenesis during 
acidosis. 
During acute acidosis (less than one day), blood GLN concentration ([GLN]) 
increases significantly [14].  This leads to an increase in the [GLN] found in glomerular 
filtrate.  To handle the increases in blood and glomerular filtrate, transport of GLN into 
the proximal tubule increases at both the apical brush border and basolateral sides of the 
cell.   Approximately one-third of the GLN in the blood that enters the cell is deamidated 
by mitochondrial glutaminase and then deaminated by Glutamate dehydrogenase  
resulting in a pronounced increase in NH4
+
 produced from the GLN that enters the cell 
(Figure 1.1).  The increased GLN utilization and NH4
+
 excretion are supported by 
increased levels of mitochondrial glutaminase and Glutamate dehydrogenase protein. 
 α−ketoglutarate conversion to succinyl CoA by α-KG-dehygrogenase  produce one 
HCO3
-
 molecule.  Subsequent metabolic steps lead to the production of malate.  The 
malate is then transported to the cytosol and consumed in the synthesis of glucose [30, 
31].  Following conversion in the cytosol to oxaloacetate by cytosolic malate 
dehygrogenase, another HCO3
-
 is released during conversion to phosphoenolpyruvate by 
PEPCK.   
     As a result of GLN catabolism during MA as outlined during these steps, a net 
of two NH4
+
 ions and two HCO3
- 
ions are produced to help restore blood pH.   
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Figure1.1  Overview of GLN metabolism in response to chronic acidosis at the 
proximal convoluted tubule.  The proximal tubule responds by increasing synthesis of 
genes involved in ammoniagenesis, bicarbonate production and gluconeogenesis.  Red 
arrows indicate increased abundance of gene products.  Green arrows indicate increased 
metabolic byproducts. Adapted from Weiner, 2007[32]. 
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Additionally, for each GLN metabolized, a net ½ glucose molecule is produced 
during gluconeogenesis. 
 
1.5 PCT response to metabolic acidosis 
  During acute (<1 days) MA, renal GLN extraction rapidly increases. As plasma 
GLN increases, renal extraction of GLN from the filtrate increases. Additionally, the 
abundances of PEPCK and mitochondrial glutaminase are increased due to the increased 
transcription of their mRNAs.  Subsequently, PEPCK, mitochondrial glutaminase and 
Glutamate dehydrogenase mRNAs are stabilized by cytosolic factors possibly aiding in 
the chronic response to acidosis.  The increases in mRNA half lives lead to a long term 
increase in protein levels during chronic metabolic acidosis[18, 33-36].  These in turn 
probably aid the increased catabolism of GLN. 
During chronic (> 1 day) acidosis, the transcription and/or stability of several 
mRNAs increase to handle the increased influx of cellular GLN.  The mitochondrial 
phosphate dependent glutaminase  (KGA), glutamate dehydrogenase, and 
phosphoenolpyruvatecarboxy kinase (PEPCK) all increase in abundance.  To aid with 
flux across the proximal tubule cell membrane, the abundances of the electrogenic 
Na
+
/3CO3 
-
 cotransporter 1 (NBCe1), system N glutamine transporter 1 (SN1), and the 
apical Na
+
/H
+
 cotransporter 3 (NHE3) all increase [37-40].  Increased influx of GLN is 
aided by the SN1transporter.  Ammonium excretion to the lumen is facilitated by the 
NHE3 antiporter leading to a general acidification of the urine, while NBCe1 aid in the 
recovery of HCO3
-
 [39].   Overall, the increased abundances of these proteins contribute 
to the ability of the proximal tubule cell to increase flux and metabolism of glutamine in 
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the cell, the net excretion of acid from the body as ammonium salts, and the attempt to 
restore blood pH by production of bicarbonate [41].   
 
1.6  Proximal Tubular Physiology 
The proximal convoluted tubule (PCT)  is the earliest part of the nephron after the 
glomerulus.  The cells are polarized epithelia containing an apical brush border which aid 
with the reabsorption of solutes that pass through the glomerulus. Typical glomerular 
filtrate contains salts (Na
+
, Cl
-
, K
+
), phosphate, urea, and glucose in addition to peptides 
(<10kDa).  The large surface area of the brush border aids in the selective readsorption of 
most of these solutes during normal cell function.  In addition, the PCT aids in the 
maintenance of physiologic function including acid-base homeostasis, regulation of blood 
glucose and recovery of protein.  Recoverable ions and other small molecules are 
transported via vectorial transport processes usually in a Na
+
-dependent manner. These 
include recovery of glucose by the Na
+
-dependent glucose symporter (SGLT2) [42, 
43]and amino acids by various solute carrier family members whose gradient potentials 
are maintained by the basolateral Na
+
/K
+
 ATPase[44, 45].  Larger peptides and molecules 
are recovered by the cell’s megalin, cubulin  and Disabled Homologue 2 (DAB2) 
endocytic machinery[46] and supply an important mechanism for protein recovery during 
normal normal condition and during stress such as renal failure[47, 48].     
 Recently, there has been an increase in the interest of controlling the glucose 
readsorptive process by selectively inhibiting SGLT2[49, 50].  This process has been 
considered important for aiding in altering the proximal tubular function during type 2 
diabetes.   In these studies, selective inhibitors of SGLT2 successfully decreased blood 
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glucose levels by modulating the ability to excrete glucose into the urine (glusocuria). 
While further validation of the total physiological effects of these selective inhibitors 
remains to be determined, the importance of further elucidating the markers of the PCT 
brush border membrane during pathology is evident.  This is due to the important role the 
PCT contributes toward the recovery of  solutes from filtrate and the maintanence of 
acid-base during such pathologic events such as diabetes and MA.  This suggests that 
studying the effect of acidosis on the brush border membrane can give insight into 
potential novel mechanisms for the MA response in concordance with the causative 
disease. 
 
1.7 Proximal convoluted tubular brush border membrane physiology 
 
The PCT apical membrane supports multiple functions.  One such function is the 
reabsorption of organic solutes passively filtered by the glomerulus.  This filtrate includes 
peptides, organic solutes (glucose, amino acids), phosphate, inorganic ions and water.  Of 
these solutes, the PCT actively recovers nearly all the glucose present (> 90%) through a  
process that is facilitated by the sodium glucose tranporter 2[42, 43].   Such processes are 
typically accomplished by facilitated co-transport with Na
+ 
as the counter ion, via a Na
+
 
concentration gradient that is maintained by the basolateral Na
+
/K
+
 ATPase.  The Na
+
 
gradient also contributes to the acidification of luminal fluid, a process that requires Na
+
 
coupled H
+
 transport via the apical sodium hydrogen exchanger 3.  A vacuolar H
+
-
ATPase (V-H
+
ATPase) also contributes to the acidification of the luminal fluid[51].  
Additional functions of the brush border include peptidase activities via dipeptidyl 
peptidase 4, glutathione metabolism via γ-glutamyltranspeptidase 1 (GGT1) activity, and 
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Megalin and Disabled homologue 2 (Dab2) mediate the endocytic mechanism for 
receptor mediated endocytic recovery of molecules into the PCT[52-56].   
 
1.8 Brush border membrane physiology during acidosis 
 Glutamine uptake and ammonium and bicarbonate ion release from the proximal 
tubule is handled by transport processes at both the basolateral and apical membranes.  In 
recent studies of two and seven days acidotic mice, the SN1, NHE3, and NBCe1 
transporters all increased in abundance as indicated by quantitative real time PCR (qRT-
PCR) and validated by Western blot and immunoflouresence [37, 40, 57].  Additionally, 
the heterodimeric cationic L type amino acid transporter 1 (y
+
LAT1) decreased in 
abundance.  Most interestingly, SN1 expression, which is found predominately in the S3 
segment or proximal straight tubule cells during normal acid-base balance, increases 
during chronic acidosis in the basolateral membrane of the S1 and S2 segments of the 
proximal convoluted tubule [40].  It was suggested that as a result of this response, 
glutamine was preferentially transported into the cell from the basolateral surface for 
subsequent phosphate-dependent glutaminase activity.   However, previous data 
produced by Foreman et. al indicated that glutamine is also extracted from the lumen via 
an alternate apical transport mechanism during acidosis[58]. 
 In 1983, Foreman isolated brush border and basolateral membranes from kidneys 
of 10 day acidotic rats.  These were assayed for [
14
C]-L-glutamine transport in the 
presence of NaCl.   The results indicated little change in the transport of glutamine in 
basolateral membranes for the acidotic versus control group.  However, the brush border 
membrane vesicles showed a 1.9 fold increase in Vmax for glutamine in acidotic rats (Vmax 
= 4.8 control versus 9.8 acidotic expressed as nmol / 15s / mg protein).   The studies 
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completed by Moret utilized mRNA and membrane protein isolated from total kidney 
whereas the study by Foreman utilized brush border membrane vesicles (BBMV) isolated 
from dissected cortex.  Both studies elucidated mechanisms for GLN uptake by both 
basolateral and apical sides of the cell.  Additionally,  the data produced in both studies 
was strongly influenced by cell type heterogeneity that was introduced by the source of 
the sample being assayed. The samples produced in both studies were from cortical 
homogenates which contain PCT (S1 and S2), proximal straight tubules (S3), and partial 
segments of the thick ascending limb and collecting duct.   
 In addition to transport function, the apical membrane in proximal tubules may 
contain additional uncharacterized proteins that may initiate a response to acidosis.  For 
example, the endothelin receptor mediates the increase in NHE3 transcription and protein 
abundance [59, 60].   In addition, NHE3 mRNA and protein abundance are reduced upon 
parathyroid hormone (PTH) stimulation in cultured opossum kidney cells. [61, 62].  
NHE3 function is also modulated by its interaction partners in a 9 protein complex 
including NHERF1/2 [63, 64].   These altered abundances and interactions could be 
detected further elucidated using a global expression profiling technique. 
During pathogenesis of metabolic acidosis, the PCT brush border membrane 
responds by increasing the abundance of NHE3 to handle the increased excretion of  
ammonium ions by aiding in the acidification of the urine [65-67].  The primary transport 
mechanisms for handling the increased ammonium ion, bicarbonate ion, and glucose 
production during MA are well understood[40, 68, 69].   However, little is known about 
the additional metabolic constraints, the cellular signaling pathways and concordant 
changes in  protein abundances that are induced by MA.   Additionally, recent mRNA 
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transcript microarray, qRT PCR, and protein abundance measurements have suggested 
additional metabolic intermediates are required for maintaining the flux required to aid 
the PCT response to chronic metabolic acidosis[70-72].  However, such experiments 
have not always been clearly defined with anatomical precision and, due to the 
heterogeneity of the assays, are not considered specific to the PCT.  Thus, proteomic 
studies of PCT specific samples are ideally suited to aid in the rapid discovery of 
additional mechanisms to the response to MA.  The isolation of PCT cells from the S1 
and S2 segments may provide a more specific approach to elucidate the response to 
acidosis specifically within the proximal tubule brush border membrane. 
 
1.9 Current status of proteomic studies of proximal convoluted tubules 
 While the literature for ‘omics’ studies (transcriptomics, proteomics, genomics) of 
renal physiology and pathophysiology is extensive, such studies of the proximal tubule 
have been limited.  The earliest such study by Cheung et al.[73] utilized Percoll density 
gradient isolated PCTs to discover mechanisms about the PCT response to a low 
phosphate diet.  Bandara et al. later described the PCT stress response to the necrotic 
inducing factors 4-aminophenol (4-AP), D-serine and cisplati.  However, Bandara used 
correlation of macroscopic inspection of PCTs with an indirect proteomic analysis of the 
plasma markers[74].  Both of these studies relied on two dimensional gel electrophoresis 
(2-DE) analysis.   
 A later publication by Cutillas revealed insight into the urinary proteome during a 
form of Fanconi Syndrome known as Dent’s disease[75]. Such patients lack sufficient 
proximal tubular readsorption caused by a chloride proton antiporter 5 (Clc5) mutation. 
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This subsequently abolishes the megalin mediated PCT endocytosis and recovery of 
peptides from the urinary filtrate.  Complementary proteomic approaches (one 
dimensional gel electrophoresis (1DE) and two dimensional gel electrophoresis (2DE)) 
were used to screen urine samples from Dent’s patients.   A few additional studies 
followed which attempted to determine the effects of diabetes (etiological to MA) and an 
angiotensin converting enzyme (ACE) inhibitor on sodium uptake[76-79].  However, 
none of these studies specifically attempted to profile the PCT response to acidosis.   
       In 2007, Curthoys et al. described a proteomic approach to study the proteome of 
proximal tubule cells for 0 and 7 day acidotic rats[33].  Proximal tubules from rat were 
first isolated by Percoll density equilibrium centrifugation and then analyzed using two 
dimensional difference gel electrophoresis (DIGE).  The results identified several known 
markers for acidosis including PEPCK, Glutamate dehydrogenase, and GA.  In addition, 
novel proteins were identified as potential markers of the acidotic response.  Most 
interestingly, such proteins included those involved in glycine metabolism, fatty acid 
utilization, calcium sensing mechanisms and pyruvate utilization. However the 
identifications were generally lacking for the identification of proteins of the plasma and 
mitochondrial membranes.  This was due to the method of extraction and subsequent 
conditions for isoelectric focusing of the proteins.  Specifically, the first dimension of 
DIGE subjects proteins to isoelectric focusing.   This step required the use of mild non-
ionic detergents to maintain charge necessary for isoelectric focusing.  As such, integral 
and associated membrane proteins were not routinely identified.  But the DIGE method is 
advantageous due to the multiplexing of samples resulting in more accurate 
normalization and subsequent abundance measurements between the samples.  Potential 
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markers identified by the DIGE method were validated by western blot, and in general, 
exhibit a positive linear correlation.   
In 2008, Nowik et al. completed a microarray analysis of 0, 2, and 7 day acidotic 
mice[71].  The study utilized whole genome mouse DNA arrays hybridized with 
digoxygenin-UTP labeled cRNAs.  cRNAs were synthesized from total RNA from mouse 
kidney.  Results were validated by traditional biochemical methods including qRT-PCR, 
and western blot.  Results paralleled previously characterized changes in transcripts for 
genes involved in glutamine metabolism, ammoniagenesis and bicarbonate production 
identified with the Curthoys  approach.  In addition, several transcripts whose abundances 
changed or were differentially regulated were identified as novel markers for acidosis.    
Genes involved in cytoskeletal organization, cell proliferation, cell differentiation, and 
apoptosis were identified.  Collectively, the results from Curthoys and Nowik indicate an 
increased role in cellular processes other than the primary GLN metabolism response 
during acidosis.   
 The microarray studies by Nowik (2007) did identify several genes that are 
specific to proximal tubules.  However, the cRNAs used in their study were synthesized 
from whole kidney RNA, whereas the protein used for validation was from dissected 
proximal tubules.  Such an approach would indicate the response of several cell types in 
the kidney, and as such, are not specific to the PCT.    
          The outlined studies revealed new insight into the MA response by the PCT.  But 
the specificity of this response at the membrane can be limited by the heterogeneity of the 
sample in addition to the extraction methods. As such, first purifying the PCT for a, 
'omics' experimental approach would be ideal.  Additionally, fractionating the PCT cell 
 17
into respective compartments such as the mitochondria, cytosol, basolateral and apical 
membranes would lead to not only inferences of cellular function by the changes in 
abundance, but also by subcellular location.   
 
1.10  Enrichment of brush border membranes from PCT 
For the analysis described in this dissertation, we chose to focus specifically on 
the apical membrane.  A method using Mg
2+
/EGTA precipitation of brush border 
membrane vesicles (BBMV) was previously developed[80, 81].  This method by Biber et 
al. is advantageous due to it's simplicity and suggested specificity for brush border 
membranes from PCT (BBMVPCT).  BBMV from a cortical homogenate can be enriched 
due to the negative charge of the sialic acid modified surface moeities present in the 
luminal surface of the proximal tubule lumen at physiological pH.  Cutillas recently 
completed a proteomic analysis of cortical BBMV using this method[82].  In his 
experiment, a proteomic investigation was completed using denaturing conditions 
together with reversed phase (C18) - electrospray ionisation tandem mass spectrometry 
(C18-ESI-MS/MS).  The study elucidated a 'snap-shot' inventory of proteins present at 
the brush border which also included the identification of many integral and membrane 
associated proteins.  However, no inferences were made to the relative distribution by 
abundance of the identified proteins and were not profiled for changes during any 
pathophysiology.   As such, our analysis would be novel to the pathophysiology of the 
response of the apical membrane of the PCT to MA. 
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CHAPTER 2 
Proteomic Tools for the Study of Renal Physiology 
 
2.1 Introduction 
Proteomics in renal research has been utilized for many years, even during the 
earliest years of the discipline[83].  Concurrent with the technological advancements of 
the 1990's, many challenges for instrument sensitivity, data acquisition and analysis have 
advanced at a rapid pace.  Such advancements have contributed to the identification of 
broad changes in proteins in the kidney.  These include rapidly improving 
instrumentation and the production of large data sets, which often cannot be met due to 
the cost of data storage and instruments.  Regardless, since 1994, when 'proteomics' was 
first described by Marc Wilkins, the number of publications for proteomics in renal 
nephrology have seen a meteoric rise[84, 85].  After the first renal study in 1997 by 
Taylor et al. which sought to study the trans-golgi of MDCK cells by 2D PAGE, the 
annual publications have risen to almost 350 publications in 2009, and are trending with 
an increase in annual publications[86].    
 
2.2  2D-PAGE proteomics 
 2D- PAGE methods separate proteins based on their net charge followed by 
molecular weight based separation using SDS-PAGE.  This technique resolves intact 
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proteins which can also be quantified by their relative intensities when stained in the gel.  
Traditional stains, such as silver and coomassie based methods, have been used in the 
various studies. Other stains target phosphor-containing proteins and can indicate the 
quantitative-phosphorylative state of the protein. To identify the samples, "plugs" or 
spots  are cut from the regions of interest, then digested with trypsin and analyzed by 
mass spectrometry.  One caveat to the 2D-PAGE  methods is that they require exhaustive 
work on the part of the researcher to prepare, focus, resolve and analyze the sample, often 
requiring days to obtain the results.  Another issue that arose from development of the 
technique was that using 2-DE identifies mostly soluble proteins (not membrane bound). 
An alternative set of methods known as "shotgun" proteomics can reveal valuable data by 
including less soluble proteins such as membrane bound proteins in the analysis 
consistent with the premise for our experiments.  
 
2.3 Shotgun proteomics 
 In Shotgun proteomics, proteins of a complex mixture are digested into peptides 
with an endopeptidase such as trypsin.  The peptides are subsequently separated by high 
performance liquid chromatography (HPLC) and then analyzed using a mass 
spectrometer. Fragmentation of the peptide bonds produce a spectra representing the 
entire amino acid sequences and are matched to theoretical amino acid sequences 
contained in a protein sequence database[87].  One of the original challenges of such an 
approach was matching an identified sequence with it’s theoretical match in a sequence 
database, which were usually derived from arduous cloning and sequencing efforts.  Such 
databases were incomplete, and relied on similarity searches across taxonomy to interpret 
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the results.  In 1986, Hunt et. al described site specific cyano bromide or trypsin digestion 
and the subsequent analysis by HPLC coupled to triple quadrupole mass spectrometry 
[88]. In concordance with the predictability of peptide fragmentation into m/z values that 
represented the charged sub-peptide amino acid masses, the sequences could be matched 
by the differences of mass of the produced y and b ions.   However, the ability to identify 
peptides in a sample of complexity (100’s-1000’s of proteins versus 10-15 for the study 
by Hunt et. al) together with the computational capability to make that match was a huge 
challenge.  With the improvements in genomic sequencing technologies dependent on the 
computing age, one of the earliest advancements was made in 1994 by Eng et.al and in 
1995 by Yates et.al [89, 90].   Following Eng and Yates'  initial experiments that matched 
selected digested proteins by MALDI-MS/MS to the Protein Information Resource 
database[91], these studies successfully matched uninterpreted MS/MS spectra derived 
from lysate of E. coli or S. cerevisiae.  In addition, these experiments introduced the 
statistical spectra-sequence matching method still commonly in use today known as 
SEQUEST. 
 Since the earliest days of proteomics, the limitations of chromatographic and mass 
resolution of the available instrumentation together with the complex combination of 
proteins from tissue and cellular samples have indicated the need to simplify the sample 
mixture.  Often, this is accomplished using methods which combine two dimensions of 
separation. These usually include strong cation (SCX) or anion exchange followed by 
reversed phase (C18) high performance liquid chromatography (HPLC).    Combining 
these methods has the advantage of increasing peptide identifications from a sample 
while improving the capability of the spectra matching algorithms due to the decreased 
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noise produced in the spectra.   One negative aspect of this approach is the inclusion of an 
additional sample processing step to enable compatibility of the mobile phase for the first 
separation (containing salts)  with those of the second separation step (typically organic 
solvents).  There has been success at combining these stationary phases into a single 
column known as multidimensional protein identification technology (MUDPIT)[92].  
This method reduces the sample loss between separation phases. However, typical 
applications of this technology utilize two separate columns on an automated HPLC 
coupled directly to a mass spectrometer.  The sample must flow through two separate 
circuits to bind and elute from the first column (SCX) prior to binding and being eluted 
from the second column (C18).  The alternative to this method is to perform the first 
separation using offline HPLC (not eluting directly into the mass spectrometer) or 
microfuge columns with the appropriate stationary phase.  Both of these methods reduce 
the sample complexity and increase the peptide and protein identifications by MS/MS. 
However, these separation techniques subsequently lead to loss of sample and /or a 
decrease in chromatographic resolution as detected at the mass spectrometer.  Regardless 
of these issues, shotgun proteomic methods provide the largest potential for increased 
protein identification if these challenges can be met. 
 
2.4 Mass spectrometry instrumentation 
There are a wide array of instruments available for use in proteomics.  For 
shotgun based methods, instruments with an attached HPLC elute samples directly into 
the instrument through an emitter spray tip known as electrospray ionization (ESI).  
During ESI, sample is ionized by a voltage potential as the molecules partition to the 
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surface of the droplets.  These droplets then desolvate until only the charged particles are 
left and then enter the mass spectrometer.  The peptides are acidified usually with TFA or 
formic acid prior to chromatography.  Once these charged and ionized peptides enter the 
instrument, they are subjected to precursor ion detection and selection followed by 
collision induced dissociation (CID) or "fragmentation" of the precursor ion to produce 
uninterpreted MS/MS spectra.   Two such instruments that accomplish this are the 
Thermo-Finnigan linear ion trap mass spectrometer (LTQ) and the Agilent 6520 
quadrupole time of flight (QTOF) mass spectrometer (MS).   
 The principal mode of operation of the LTQ MS is the trapping of ions in an 
electromagnetic field[93].  As ions enter the instrument, a magnetic field traps the ions 
between four magnetic poles and has an ejection path axial to the poles alignment[94].   
Upon capture of the precursor ions,  2 dimensional radiofrequency fields are used to filter 
peptides based on the peptide ions' polarity and mass to charge ratios (m/z).  
Subsequently, the charged peptides are selected for fragmentation, typically by CID 
followed by detection using a mass analyzer and amplification of the signal using an 
electron multiplier.   The LTQ also has the advantage of the ability to trap ions from the 
entering sample, leading to selective amplification of the detected signal.    
 The QTOF instrument filters ions by m/z in a manner similar to the LTQ. 
However, the QTOF continually ejects ions into a second quadrupole for further selection 
by m/z of the precursor ions prior to CID.  The instrument is continually switching from 
detection of MS precursor ions in the first quadrupole (Q1) to filtering and CID of the 
selected precursor by the second quadrupole (Q2). Both MS and MS/MS scans are 
resolved by the time of flight tube followed by detection with the aid of a reflectron to 
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condense the selected ions into a smaller time space[95].  The Agilent QTOF has a mass 
error for the precursor ions of ~ ± 5-7 ppm (as produced in our lab) and a mass resolution 
of ~10-15,000. As such, it is considered a high mass accuracy instrument and can resolve 
the natural 
12
C/
13
C
 
isotopic distribution over the mass range typical for peptides (150-
3000 m/z).  Additionally, the TOF portion of the instrument can detect peptides and larger 
proteins over a larger selection of mass ranges (25-200,000 Da).  Both instruments have 
similar duty cycle times for switching between selecting precursors for fragmentation, 
performing the fragmentation, and collecting the data. The described instrumentation is 
ideal for performing  a 'snapshot' inventory of the peptides present in a sample, but are 
also ideally suited for analysis of relative abundance between samples.   
 
2.5 Quantitative proteomics using labeled peptides 
 While shotgun proteomics can identify peptides by matching MS/MS spectra to a 
sequence database, sequence information alone is insufficient for abundance 
measurements.  Several methods exist to aid in the determination of relative abundance 
measurements.  These include chemical labeled and non-labeled techniques.   
 Isobaric tags for relative and absolute quantitation (iTRAQ) reagents are 
commercially available (AB Sciex) compounds that allow the simultaneous 
determination of the relative abundance of proteins from different samples[96].  The 
labels are covalently linked to the N- terminus of each peptide.  Prior to fragmentation of 
peptides in the mass spectrometer, the reporter ion plus the cleaved tag all have the same 
mass (are isobaric).  Upon selected fragmentation, the isobaric tags are cleaved to liberate 
a reporter molecule of which the intensity can be measured.  The selective mass range of 
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the tags (114-118 Da) is below the working mass range of the LTQ.  Therefore, detecting 
the labeled peptides requires switching fragmentation energies for shorter time periods to 
selectively fragment the tag followed by CID of the peptide itself[97]. The intensity 
measurement of the tag is used to measure the abundance of the peptide.  Inferences of 
protein abundance are made by combining peptide abundance measurements per protein.  
Similarly, isotope-coded affinity tags (ICAT) and (+)-biotinyl-iodoacetamidyl-3,6-
dioxaoctanediamine (iodoacetyl-PEO-biotin) can be used to label the cysteine residues of 
peptides[98]. These biotynylated labels, when conjugated to the cysteine residue, can be 
selectively enriched by avidin-biotin affinity purification.  Such labels enable the 
simultaneous identification of peptides from multiple sample groups (4-8 for iTRAQ, and 
2 for ICAT)  mixed into one sample for analysis (multiplexing).  Stable isotope labeling 
with amino acids in cell culture (SILAC) utilizes 
13
C or 
15
N labeled amino acids that are 
metabolically incorporated into the proteins[99].  This method was developed for use 
with cell culture.  However, recent work has shown some success at breeding rats which 
were fed a diet enriched in 
15
N[100].  These labeled methods are advantageous due to the 
multiplexing which  can reduce instrument time.  They also permit the direct detection of 
abundance ratios from a single mass spectrometry experiment that are reliable down to a 
1.5 fold change over a dynamic range of 1.5-1000 fold[101-103].   However, the labels 
are expensive, are limited to a subset of peptides (ICAT) and require testing for chemical 
labeling efficiency (in the case of ICAT or iTRAQ) or metabolic incorporation (SILAC).  
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2.6  Label-free quantitative proteomics:  Spectral Counting 
       By far spectral counting has become the de facto standard for non-labeled relative 
quantitative proteomics in the basic sciences.  Spectral counting relies on the random 
sampling of spectra by the mass spectrometer producing a pseudo-count for each time a 
peptide is identified[104]. Larger and more abundant proteins are proteotypically 
represented in an experiment by more MS to MS/MS transitions which identify that 
protein. By altering the dynamic data acquisition of the instrument, the counts per peptide 
(and thus, the protein) can be optimized. In 2004, Liu et. al tested standards spiked in a 
yeast lysate.  The results produced data that were linear over 2 orders of magnitude.  In a  
later study by Old et. al, abundance ratios determined by spectral counting(SpC) of spike 
in standards in a complex background of protein were shown to positively correlate with 
analysis by peak area (r=0.96) and gel band intensity measurements (r=0.90)[103]. In yet 
another study by Hendrickson et. al, SpC abundance ratios were shown to positively 
correlate to results produced using SILAC, but with reduced sensitivity for detecting a 2-
fold change[105].  Since SpC data is count data, it typically is not normally distributed 
and therefore presents a challenge to successfully infer significance of altered abundance.  
This is partly due to the dependency on the mass spectrometer's dynamic selection of MS 
precursors together with the sample complexity. Additionally, count data is not an actual  
measurement of abundance such as peak intensity.  These limitations combine to make 
SpC data more difficult to assess abundance changes when the SpC are low.  A promising 
approach to circumvent these issues is to combine the count data from multiple injection 
replicates of the same sample. This can increase the SpC per protein increasing the 
sensitivity to detect a change in abundance.  By increasing the SpC per protein, the 
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variability of the SpC per protein decreases. SpC data can be sensitive enough to detect 2 
fold changes with a high enough sensitivity that is nearly 80% when the SpC per protein 
is a minimum of 10 for a total of 3 replicates [106].  Thus, increasing SpC per protein 
together with the number of  replicates increases the sensitivity for detection of 
abundance measurements. 
 Spectral counting is advantageous due to the simplicity of it's use.  There are no 
extra sample handing steps as required with chemical labeling which may result in 
sample loss.  More time on the instrument is required to inject the multiple samples for a 
comparison study.  However, the statistical power of the technique can be acquired with 
careful planning and experimental design. 
 
2.7  Label-free Quantitative proteomics: precursor ion peak intensity and AMT 
 Another label free method is to measure the peak intensities of the precursor ions 
using LC-MS. Using this method, MS peaks can be visualized with a 2D digital map 
comparing retention time versus m/z (figure 2.1).  The maps obtained from multiple 
samples can then be aligned by non linear regression. This alignment can be 
accomplished by a number of different software packages including OpenMS, msInspect, 
and XCMS[107-110]. The abundance measurements are then compared for the aligned 
maps.  There are two primary methods for the LC-MS based approaches.  In the first 
method, a targeted list of peptides from aligned LC-MS maps are later identified using 
MS/MS[111].  This method provides validation of the  LC-MS features while still 
allowing the more accurate abundance measurement of MS alone.  The other method 
similarly aligns LC-MS features, but identification is inferred from seperate LC-MS/MS 
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injections.  The basis for this approach is the reproducibility of the detection of a peptide 
by it's hydrophobicity (retention time) together with it's monoisotopic mass [112]. If the 
mass accuracy of the mass spectrometer is high enough, the RT and m/z can provide an 
accurate identification of the peptide feature.  Additional confidence can be assigned to 
the mass tag if hydrophobicity of the peptide is calculated[113]. Decreasing the elution 
time using reversed phase HPLC from 60 minutes to as little as 5 minutes can still result 
in highly reproducible observed hydrophobicities when using AMT[114].  ESI-TOF with 
± 15ppm error of the matched feature was sufficient for these rapid 2-5 minute 
chromatography separations when resolving ~ 120 proteins.  Additionally, the utility of 
ultra performance liquid chromatography toward AMT has been determined[115]. Shen 
et. al showed that using 50µm inner diameter  capillary C18 HPLC could produce 250 to 
550 protein identifications by MS/MS in 8-20 minutes. These early experiments used 
ESI, whereas nanospray technology is more commonly in use today.   
       The methods using accurate mass and time tag (AMT) technology have been limited 
in  use, probably due to the general availability and expense of mass spectrometers with a 
high mass accuracy.  The complexity of a typical whole cell lysate contains 10,000 
potentially detectable tryptic peptides.  Additionally, the typical mammalian rat and 
human genome contains millions of theoretical peptides that a feature could be matched 
against.  Taken together, these indicate is necessary to reduce the sample complexity 
together with the use of the highest mass accuracy instrument available if the 
experimenter wishes to utilize AMT technology.   
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Figure 2.1. Digital 2-D map of C18-NSI-MS data. A) The collected data is visualized in 
two dimensions, retention time (x axis) versus m/z. Relative intensity is a measurement of 
abundance for a peptide. trace at the bottom is of total ion current.  B) m/z scan for a 
peptide. The mono-isotopic 
12
C/
13
C distribution of peaks are shown. C) Extracted ion 
chromatogram for the peptide in B as eluted over the duration of several seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1
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Statement of Problem and Aims 
        To date, only a few 'omics analysis of the response to metabolic acidosis have been 
completed. Studying the proximal convoluted tubular response to metabolic acidosis 
would increase the knowledgebase for further hypothesis driven research while revealing 
novel mechanisms for the response.  Furthermore, the analysis at the brush border 
membrane would reveal the effect of compartmentalization of this repsonse within the 
cell.  Such an effect could be masked if the total abundance of proteins in the cell.  To 
reveal these changes at the brush border membrane, the following experiments will be 
completed: 
 
1. Characterize the inventory of proteins at the brush border membrane of proximal 
convoluted tubule cells.  Determine the reproducibility  and purity of the enriched brush 
border membrane samples and then perform a shotgun proteomic analysis using ion trap 
mass spectrometry and spectral counting. 
 
2.  Profile the global abundance changes that occur at the brush border membrane during 
1-d, 3-d, and 7-d metabolic acidosis.  Using QTOF mass spectrometry and spectral 
counting, test the relative changes in abundance of the proteins detected. In addition,  
establish the reproducibility of the peptides elution profiles obtained from multiple 
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injection and biological replicates to determine if accurate mass and time tags can be 
developed from the identified peptides. 
 
3.  Perform more accurate relative quantification of the profiled peptides using liquid 
chromatography QTOF mass spectrometry.  Using the AMT database and spectral counts 
developed in 2, peptide level quantification will be performed and then compared to the 
protein level abundance measurements  that are determined by spectral counting. 
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CHAPTER 3 
Proteomic Analysis of Brush Border Membrane Vesicles 
Isolated from Purified Proximal Convoluted Tubules 
 
This chapter describes work published in the American Journal of Physiology: Renal 
Physiology  
Scott J. Walmsley et. al, 2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Walmsley SJ, Broeckling C, Hess A, Prenni J, Curthoys NP. Proteomic analysis of brush-
border membrane vesicles isolated from purified proximal convoluted tubules. Am J 
Physiol Renal Physiol. 2010 Jun;298(6):F1323-31. 
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3.1 Abstract 
The renal proximal convoluted tubule is the primary site of water, electrolyte and 
nutrient reabsorption and of active secretion of selected molecules. Proteins in the apical 
brush border membrane facilitate these functions and initiate some of the cellular 
responses to altered renal physiology. The current study uses 2-dimensional liquid 
chromatography/mass spectrometry to compare brush border membrane vesicles isolated 
from rat renal cortex (BBMVCTX) and from purified proximal convoluted tubules 
(BBMVPCT). Both proteomic data and western blot analysis indicate that the BBMVCTX 
contain apical membrane proteins from cortical cells other than the proximal tubule. This 
heterogeneity was greatly reduced in the BBMVPCT. Proteomic analysis identified 194 
proteins common to both samples, 20 proteins unique to BBMVCTX, and 57 proteins 
unique to BBMVPCT. Spectral counts were used to quantify relative differences in protein 
abundance. This analysis identified 42 and 53 proteins that are significantly enriched (p 
values ≤ 0.001) in the BBMVCTX and BBMVPCT, respectively. These data were validated 
by measurement of γ-glutamyltranspeptidase activity and by western blot analysis. The 
combined results establish that BBMVPCT are primarily derived from the proximal 
convoluted tubule (S1 and S2 segments), whereas BBMVCTX include proteins from the 
proximal straight tubule (S3 segment). Analysis of functional annotations indicated that 
BBMVPCT are enriched in mitochondrial proteins and enzymes involved in glucose and 
organic acid metabolism. Thus, the current study reports a detailed proteomic analysis of 
the brush border membrane of the rat renal proximal convoluted tubule and provides a 
database for future hypothesis driven research. 
 
Key Words: rat kidney, apical membrane, spectral counting, membrane proteins 
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3.2 Introduction 
The proximal tubule is the most abundant segment of the nephron within the renal 
cortex [116]. It is composed of polarized epithelial cells and consists of three sub-
segments (S1, S2, and S3) that differ in protein composition and function. The primary 
functions of the entire proximal tubule are the recovery of approximately 80% of the fluid 
and electrolytes from the glomerular filtrate, the reabsorption of > 99% of the filtered 
glucose and other nutrients, and the active secretion of selected molecules. These 
processes are facilitated by a unique set of largely Na
+
-independent transporters in the 
basolateral membrane that promote exchange of solutes with blood and a separate set of 
primarily Na
+
-dependent transporters in the apical brush border membrane that facilitate 
exchange with the glomerular filtrate. In addition, the brush border membrane also 
contains multiple hydrolases and proteins involved in receptor-mediated signaling.  
Previous analyses of the brush border membrane have primarily utilized brush border 
membrane vesicles (BBMV) that were isolated by MgCl2 precipitation from renal cortical 
homogenates [81]. Such studies have included the functional characterization of 
transporters such as the Na
+
-dependent glucose [42] and phosphate [117] transporters, of 
NHE3, the apical Na
+
/H
+
 exchanger [118], and of various peptidases and disaccharidases 
[119]. While these studies sought to characterize the function of a single protein, a recent 
analysis utilized a shotgun approach to define the proteome of BBMV isolated from rat 
renal cortex [82]. This approach offers the potential of creating a comprehensive 
inventory of the protein composition of the brush border membrane. In addition, a 
thorough proteomic characterization of highly purified brush border membranes would 
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provide additional insight into the processes mediated by the proximal tubule during 
normal physiology. It would also provide the basis to characterize alterations in the 
proteome that are associated with the loss of specific functions during pathological 
conditions such as hypoxic or toxic injury to the proximal tubule. 
However, due to the presence of multiple cell types and the subtle differences 
between the segments of the proximal tubule, it may be difficult to accurately define the 
protein composition using BBMV isolated from renal cortex. For example, BBMV 
prepared from micro-dissected proximal convoluted and proximal straight tubules exhibit 
differences in kinetic parameters of glucose uptake, indicative of cell specific expression 
of different isoforms [120]. In addition, immunofluorescence studies have demonstrated 
that numerous proteins are preferentially expressed in the individual segments of the 
proximal tubule. For example, γ-glutamyltranspeptidase expression is greater in the 
proximal straight tubule (S3 segment) than in the proximal convoluted tubule (S1 and S2 
segments) [54, 121, 122]. Together, these results demonstrate that an accurate assessment 
of the localization of specific proteins by proteomic analysis may require the further 
enrichment of BBMV from specific segments of the proximal tubule. 
In this study, 2-dimensional liquid chromatography/mass spectrometry (LC-MS/MS) 
was used to compare the proteome of BBMV prepared from rat renal cortex (BBMVCTX) 
and from isolated proximal convoluted tubules (BBMVPCT). This approach, along with 
immunoblot analysis of marker proteins, indicated that the BBMVCTX preparation also 
contains apical membranes that are derived from cells of the renal cortex other than the 
proximal tubule. However, the initial isolation of proximal convoluted tubules by Percoll 
gradient centrifugation was sufficient to remove the identified contaminants from the 
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BBMVPCT preparation. The comparative proteomic analysis also revealed significant 
differences between the two samples. This analysis, along with the observed differences 
in γ-glutamyltranspeptidase activity, indicates that the BBMVPCT are derived primarily 
from the S1 and S2 segments of the proximal tubule. Conversely, only the BBMVCTX 
contain proteins that are expressed solely in the S3 segment and exhibit higher levels of 
proteins that are enriched in the proximal straight tubule. Finally, an analysis of 
functional annotations indicates that BBMVPCT are enriched in enzymes of glucose 
metabolism, organic acid catabolism, and mitochondrial proteins. Therefore this study 
provides the first detailed proteomic analysis of the brush border membrane of the rat 
renal proximal convoluted tubule.  
 
3.3 Materials and methods 
3.3a Materials 
Rabbit polyclonal antibodies versus GLUT2 and Calnexin (H-70) were purchased 
from Chemicon International (Billerica, MA) and from ABCAM Inc. (Cambridge, MA), 
respectively. A mouse monoclonal antibody to the 70 kDa subunit of succinate 
dehydrogenase was from Mitosciences (Eugene, OR). Rabbit polyclonal antibodies raised 
against aquaporin-2, thiazide-sensitive Na
+
Cl
-
 co-transporter and Na
+
K
+
2Cl
-
 co-
transporter-2 were kindly provided by Dr. Mark Knepper (NIH, Bethesda, MD). Mouse 
monoclonal antibodies to Na
+
/H
+
 exchanger-3 were kindly provided by Dr. Orson Moe 
(Southwestern Medical Center, Dallas, TX). Male Sprague-Dawley rats (~200g) were 
obtained from Charles River Laboratories (Kingston, NY) and were fed rodent chow 
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(Harlan-Teklad, Madison, WI) and tap water. All procedures were approved by the 
Institutional Animal Care and Use Committee at Colorado State University.    
 
3.3b Purification of proximal convoluted tubules  
Rat renal proximal convoluted tubules were isolated by Percoll density gradient 
centrifugation [33]. Briefly, approximately 1 mm
3
 pieces of excised kidney cortex were 
incubated in phosphate-buffer saline (PBS) containing 5 mM glucose, 1 mg/ml bovine 
serum albumin, 0.1 mg/ml DNAse, 2 mg/ml collagenase B (Roche Diagnostics, 
Mannheim), 1 mM heptanoic acid, 1 mM phenylmethylsulfonyl fluoride, and 1 mM 
sodium orthovanadate. The resulting tubules were washed twice in PBS containing 5 mM 
glucose to remove collagenase and then resuspended in an osmotically and pH balanced 
PBS solution containing 5 mM glucose, 45% Percoll (Sigma Life Sciences), and 10 mM 
Hepes, pH 7.4. After centrifugation, the tubules were recovered from a band that formed 
near the bottom of the gradient and were washed twice with PBS containing 5 mM 
glucose to remove the Percoll. 
 
3.3c  Isolation of Brush Border Membrane Vesicles  
Brush border membranes vesicles (BBMV) were prepared using the standard method 
of MgCl2 precipitation [80, 81]. Excised kidney cortex or purified proximal convoluted 
tubules were resuspended in 10 volumes (vol./wet wt.) of a solution containing 300 mM 
mannitol, 5 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium 
orthovanadate and 12 mM Hepes, pH 7.1. After Polytron homogenization (90 sec, setting 
5), the homogenate was diluted 2-fold with H20 and then MgCl2 was added to yield a 
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final concentration of 12 mM. The mixture was then incubated on ice for 15 min with 
intermittent and gentle mixing. Following centrifugation at 3,000 x g for 10 min at 4
o
C to 
remove mitochondria and cellular debris, the resultant supernatant was centrifuged at 
30,000 x g for 40 min at 4
o
C to pellet the BBMV.  The pellet was then resuspended in 1 
volume of 150 mM mannitol, 2.5 mM EGTA, and 6 mM Hepes, pH 7.1 and 
homogenized with 15 passes of a glass Teflon homogenizer. The BBMV were again 
precipitated by addition of 12 mM MgCl2 and repetition of the incubation and 
centrifugation steps. The final pellet was resuspended in the previous mannitol buffer and 
the BBMV were stored at -80
o
C. 
 
3.3d   γ-Glutamyltranspeptidase assay and immunoblot analyses 
 Aliquots of cortical homogenate and the isolated BBMV were assayed for protein 
[123] and γ-glutamyltranspeptidase activity [124]. The specific activity (µmol·min
-1
·mg
-
1
) was determined by quantifying the liberation of p-nitroanaline from γ-glutamyl-p-
nitroanaline (Sigma-Aldrich) with glycylglycine (Sigma-Aldrich) as the acceptor. For 
immunoblot analyses, samples containing 20 µg of protein were separated by 7% or 10% 
SDS-PAGE. Following transfer to PVDF membranes (Immobilon-FL, Millipore), the 
blots were incubated overnight with either mouse monoclonal or rabbit polyclonal 
antibodies. Either 680 or 800 Dylight conjugated goat anti-mouse or goat anti-rabbit IgG 
(Pierce) was used as secondary antibody (1:10,000 (v/v)). The resulting complexes were 
visualized and quantified using an Odyssey Infrared Imager (LI-COR Biosciences, 
Lincoln, NE). 
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3.3e  Sample Preparation and Mass Spectrometric Analysis  
         Aliquots of BBMV containing 100 µg of protein were denatured by heating at 95
o
C 
for 5 min. After cooling to room temperature, the samples were dried and reconstituted to 
3 mg/ml in 8 M urea. The ultra-sonicated samples were reduced (14 mM dithiothreitol, 
30 min, 37
o
C) and alkylated (5 mM iodoacetamide, 1 h, 37
o
C) and then diluted 5-fold 
with 100 mM ammonium bicarbonate, pH 8.0. Sequencing grade modified tryspin was 
added (1:30, enzyme:protein) and the samples were incubated for 16 h at 37
o
C.  The 
resulting peptides were desalted on a PepClean-C18 spin column (Thermo Scientific), 
normalized by measuring the absorbance at 220 nm (Nanodrop), and fractionated by 
strong cation exchange (SCX) chromatography. For SCX fractionation, the peptides were 
bound to a Polysulfoethyl-A microspin TopTip (Glygen) and eluted stepwise with 20 µl 
volumes of increasing ammonium acetate (20, 40, 60, 80, 120, 160 and 200 mM) in 20% 
acetonitrile, pH 2.9-3.8 to yield a total of 7 fractions.  The peptides were then dried 
(SpeedVac) and reconstituted in 30 µl of 0.1% formic acid/3% acetonitrile. Each fraction 
was analyzed in triplicate by injecting 7 µl aliquots onto a Biobasic C-18 PicoFrit reverse 
phase nanospray column (74 µm ID x 10 cm, New Objective). Peptides were eluted 
directly into an LTQ mass spectrometer (Thermo Scientific) using a 90 min linear 
gradient of 15%-45% acetonitrile in 0.1% formic acid at a flow rate of 300 nl/min. MS 
spectra were collected over an m/z range of 200-2000 Da.  MS/MS spectra were collected 
for the 5 most abundant ions in each MS scan using a dynamic exclusion limit of 2 
MS/MS spectra of a given mass for 30 sec with an exclusion duration of 90 sec. 
Compound lists of the resulting spectra were generated using Bioworks 3.0 software 
(Thermo Scientific) with an intensity threshold of 5,000 and 1 scan/group. 
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3.3f  Bioinformatic analysis  
     The resulting mass spectra were searched against the Rat-IPI database (v.3.57) using 
SEQUEST and X!Tandem (v.2008.12.01) search engines [90, 125, 126]. Each search was 
performed with a mass tolerance of 2.5 Da for MS and 1.0 Da for MS/MS spectra and 
with settings for tryptic peptides with up to 2 missed cleavages and 
carbamidomethylation of cysteine as a fixed modification and oxidation of methionine as 
a variable modification. Peptide false discovery rates (FDR) were determined by a target 
decoy approach using a reversed database concatenated to the parent forward database 
[127, 128]. The results of the searches were combined and protein identifications were 
validated using Scaffold (Proteome Software).  Protein identifications with delta Cn 
values ≥ 0.2 and Xcorr scores ≥ 2.0 (z
+1
), ≥ 2.4 (z
+2
), and ≥ 3.7 (z
+3
) for SEQUEST and 
Expect scores ≥ 1.0 for X!Tandem were entered in Scaffold (v.2.02) to produce a FDR of 
≤ 1%. Lists of total proteins were assembled using a minimum of 2 identified peptides in 
at least one of the biological replicates of each BBMV preparation as an additional 
threshold for protein identification.  
The relative abundance of the identified proteins in the BBMV isolated from cortex 
(BBMVCTX) or from purified proximal convoluted tubules (BBMVPCT) was determined 
by spectral counting (32). Similarity of sampling across injections was tested by 
comparing the spectral counts (SpC) for each analysis. SpC were also compared by 
summing each of the SCX fractions from a single sample. A test for correlation between 
injections and between each of the biological samples was completed using the Pearson 
moment correlation function with the R statistics package (v.2.8.1) (http://www.r-
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project.org). The spectral data were compared for variance by analyzing several 
diagnostic variables. These included total spectra, total identified spectra, % of total 
spectra above the search engine threshold cutoffs, and total proteins identified. The 
diagnostics were calculated for each biological sample. Once the similarity and variance 
between the biological samples were determined, the significance of the differences in 
SpC was calculated. 
Significant changes between the BBMVCTX and BBMVPCT samples were calculated 
using the total SpC for the two biological replicates and the Fisher Exact Test [129, 130] 
to calculate p values. The p value distribution was corrected for the false positive rate 
using the method of Benjamini and Yeuketieli [131]. An adjusted p value ≤ 0.001 and a 
minimum of two identified peptides per protein were used as the cutoff for a significant 
change in protein abundance between the BBMVCTX and BBMVPCT samples. For each 
protein, the ratio of the spectral counts (RSC) in the BBMVPCT samples to the BBMVCTX 
samples was calculated using Eq. 1 [103, 132], where nCTX and nPCT are the total spectral 
counts in the BBMVPCT and BBMVCTX samples, respectively, and t is the total spectral 
counts for all of the identified proteins in each of the two samples.  
(Eq. 1)        
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Once significant differences were determined, the RSC values were plotted versus the total 
spectral counts for each protein in the combined BBMVCTX and BBMVPCT samples. The 
corrected p values were then used to visualize the distribution of the proteins that were 
significantly enriched in either BBMV preparation.   
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3.3.g Enrichment of Gene Functional Annotations  
        A list of Gene Identifier accession numbers corresponding to each IPI accession was 
created using Microsoft Access software. The list of Gene Identifiers for the two samples 
(BBMVCTX and BBMVPCT) were then used to upload the proteins into the DAVID 2008 
Bioinformatics Resources web server (http://david.abcc.ncifcrf.gov/) for analysis [133, 
134]. Lists of total proteins per sample were tested for enrichment of functional 
annotations using the suggestions of Huang et al, [134]. Rattus norvegicus was used as 
the background species to test for enrichment of Gene Ontology and Kegg Pathway 
terms. Biological process, cellular component, and molecular function were tested 
separately. Functional annotations were selected based on known inferences of cell 
function for our samples (ie., brush border membrane, proximal tubule function, 
glycolysis, etc.). Lists of interest were assembled based on these inferences and then 
expanded by manually evaluating proteins whose functional annotations were 
incomplete.   
 
3.4  Results and discussion 
3.4a  Enrichment of BBMV from cortex and from proximal convoluted tubules  
        Initially, BBMVCTX were prepared by selective MgCl2 precipitation from a 
homogenate of rat renal cortex [80]. Compared to the cortical homogenate, the isolated 
BBMVCTX exhibit a 15-fold increase in specific activity of γ-glutamyltranspeptidase, an 
apical membrane marker for the proximal tubule (Fig. 3.1). Western blot analysis (Fig. 
3.2A) also indicated that the BBMVCTX are highly enriched in the apical Na
+
/H
+
 
exchanger (NHE3), but contain greatly reduced levels of the basolateral glucose 
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transporter (GLUT2), the mitochondrial succinate dehydrogenase (SDH), and the 
endoplasmic reticulum marker, calnexin (CNX). These data are in agreement with 
previous results [80] and are consistent with the removal of other subcellular membranes. 
However, the isolated BBMVCTX exhibit increased levels of markers for the apical 
membranes of the collecting duct (aquaporin-2), the thick ascending limb, (Na
+
K
+
2Cl
-
 
cotransporter-2), and the distal tubule (thiazide-sensitive Na
+
Cl
-
 cotransporter) (Fig. 
3.2B). These data indicate that the classical preparation of BBMV also contains the apical 
membranes from cortical cells other than the proximal tubule.  
 
3.4b Proteomic analysis of BBMVCTX and BBMVPCT  
    Duplicate biological samples of BBMVCTX and BBMVPCT were analyzed by 2-
dimensional LC-MS/MS. Each sample was initially separated by off-line SCX 
chromatography to produce 7 fractions. Triplicate samples from each of the SCX 
fractions were further fractionated by on-line C18-chromatography coupled directly to an 
LTQ mass spectrometer via a nanoelectrospray source. The SEQUEST and X!Tandem 
search engines were used to match the recorded MS/MS spectra from the 84 mass 
spectrometric analyses against the current rat IPI database.  
Of the total identified proteins, 22% are integral membrane proteins and an additional 
18% are peripheral membrane proteins. However, the single largest group of identified 
proteins is those involved in metabolism. Functional analysis of the 214 proteins 
identified in the BBMVCTX samples indicated a slightly greater proportion of membrane 
transporters and a decreased level of mitochondrial proteins (Fig. 3.3C) compared to the 
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BBMVPCT samples. A complete list of the identified proteins is provided in supplemental 
Table S1. 
A comparison of the relative abundance of the 20 most abundant proteins in the 
combined BBMVPCT and BBMVCTX samples, as determined by spectral counts (SpC), is 
illustrated in Fig. 3.4. The 12 most abundant proteins are well characterized apical 
membrane proteins: α and β subunits of the Na
+
/K
+
-ATPase-1, actin, aminopeptidase N, 
low density lipoprotein receptor-2, Na
+
/H
+
-exchanger regulatory factor-3, an amino acid 
transporter (rBAT), dipeptidylpeptidase-4, maltase-glucoamylase, ezrin, villin-1, and 
Na
+
/glucose co-transporter-2.  
     The resulting identifications were validated in Scaffold using stringent criteria that 
produced a false discovery rate of ≤ 1%. This analysis identified 194 proteins common to 
both preparations of BBMV, 57 proteins unique to the BBMVPCT and 20 proteins unique 
to the BBMVCTX (Fig. 3.3A). Functional analysis of the 251 proteins contained in the 
BBMVPCT indicated that nearly 30% of the identified proteins are transporters, peptidases 
and cytoskeleton proteins that are typical of the brush border membrane (Fig. 3.3B). An 
additional 12% of the proteins are membrane receptors and proteins involved in signal 
transduction. For the most part, this set of proteins produced a similar number of SpC in 
the two samples. However, a few proteins, such as rBAT and γ-glutamyltranspeptidase, 
appear to be more abundant in the BBMVCTX than in the BBMVPCT. By contrast, 
aldolase-B, α-actinin-4, and NHE3 regulatory factor-1 appear to be more abundant in the 
BBMVPCT. Therefore, a statistical analysis of the SpC associated with the proteins  
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Figure 3.1  Enrichment of γ-glutamyltranspeptidase activity in isolated BBMV. 
Crude homogenates of rat renal cortex and of isolated BBMVCTX and BBMVPCT were 
assayed for γ-glutamyltranspeptidase activity and protein. The fold increases in specific 
activity are plotted as a bar graph +/- the standard deviation for 3 separate samples. 
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Figure  3.1
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Figure 3.2  Western blot analyses of the purity of the BBMVCTX and BBMVPCT.  
Panel A. Analysis of contaminating organelle and basolateral membranes. Samples 
containing 20 µg of crude homogenates of rat renal cortex and BBMVCTX were separated 
by SDS-PAGE and probed with antibodies that are specific for the apical (BBM) Na
+
/H
+
 
exchanger (NHE3), the basolateral (BLM) glucose transporter (GLUT2), the 
mitochondrial (MITO) succinate dehydrogenase (SDH), and the endoplasmic reticulum 
(ER) marker, calnexin (CNX). Panel B. Analysis of contaminating apical membranes. 
Samples containing 20 µg of renal cortex, isolated proximal convoluted tubules (PCT), 
and purified BBMV were probed for proteins that, within the cortex, are expressed only 
in the proximal tubule (PT), Na
+
/H
+
 exchanger (NHE3); the thick ascending limb (TAL), 
Na
+
K
+
2Cl
-
-cotransporter-2 (NKCC2); the distal tubule (DT), thiazide-sensitive Na
+
Cl
-
 
co-transporter (TSC); and the collecting duct (CD), aquaporin 2 (AQP2).  
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Figure 3.3  Proteomic Analysis of BBMVCTX and BBMVPCT. Panel A. Venn diagram 
of total proteins identified in the two BBMV samples. Panel B. Functional classification 
of the 251 proteins identified in the BBMVPCT sample. Panel C. Functional classification 
of the 214 proteins identified in the BBMVCTX samples. 
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Figure  3.3
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Figure 3.4  Comparison of the total spectral counts associated with the 20 most 
abundant proteins identified in the combined BBMVPCT and BBMVCTX samples.  
The total spectral counts (SpC) determined for each protein in the BBMVPCT and 
BBMVCTX samples are illustrated by the solid bar and the hatched bar, respectively. 
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Figure 3.4 
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identified in the BBMVPCT and BBMVCTX samples was performed to verify the 
differences in the two preparations. 
 
3.4c  Quantitative analysis of protein abundance in BBMVCTX and BBMVPCT  
       The spectral counts (SpC) collected for an individual protein increase in proportion 
to its abundance [135]. As a result, spectral counting has become the preferred method of 
quantification due to its ease of implementation compared to alternative methods that 
require chemical modification of peptides or labeling with heavy isotopes. However, to 
utilize the SpC to quantify the differences in protein abundance, the samples must be 
carefully normalized to each other and an analysis of the data should ensure that no 
significant loss of proteins or peptides occurred during the sample preparation. For the 
reported data, the standard deviation of the total identified SpC for each of the four 
biological samples expressed as a percent of the mean was only 5.6%. The same analysis 
for total spectra (unidentified and identified), percent of total spectra identified, and the 
number of protein identifications yielded values of 2.6%, 6.5%, and 7.5%, respectively. 
The highest variance was between the two BBMVCTX samples. This is probably due to 
the heterogeneity introduced by the dissection of renal cortex.  
  To further assess the consistency of replicate samples, the total SpC for each of 
the identified proteins was compared between individual injections (Fig. 3.5A) and 
between the sum of all injections (Fig. 3.5B). As expected, the greatest dissimilarity was 
observed in the SpC measured for the less abundant proteins. However, the data had 
Pearson’s correlation coefficients of r = 0.97 between representative injections and r = 
0.94 and r = 0.95 for the replicate BBMVCTX and BBMVPCT samples, respectively. 
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Therefore, the SpC measured in the multiple injections and the biological replicates were 
highly reproducible.  The Fisher’s exact  test [129] was used to identify significant 
changes in protein abundance between the BBMVCTX and BBMVPCT samples (Fig. 3.6A). 
The resulting p values were further refined using the Benjamini-Yeuketieli correction 
[131]. The criteria for identifying a significant change was set as a ≥ 2-fold change in 
total SpC and a corrected p value of ≤ 0.001. The normalized ratios of spectral counts 
(RSC) for the 271 proteins identified in the two BBMV samples were plotted versus the 
total SpC and color coded to identify proteins that are significantly enriched in either 
BBMV preparation (Fig. 3.6B). This analysis identified 42 proteins that were 
significantly enriched in the BBMVCTX and 53 proteins enriched in the BBMVPCT. The 
proteins that are significantly enriched in the two samples are italicized in supplemental 
Table S1.    
The compiled data revealed significant enrichment of several interesting proteins in 
both the BBMVCTX and BBMVPCT preparations. Functional analysis of the data indicates 
that membrane transporters constitute 45% of the proteins enriched in the BBMVCTX (Fig 
3.7A), but only 21% of the total proteins identified in the BBMVCTX (Fig. 3.3C).  
Some of the proteins that are significantly enriched in the BBMVCTX are illustrated in 
Fig. 3.8.  The RSC values are the log2 of the normalized ratios of SpC in the BBMVPCT to 
the BBMVCXT samples. Included in this list are the thiazide-sensitive Na
+
Cl
-
 
cotransporter and the Na
+
K
+
2Cl
-
 co-transporter-2 that are derived from the apical 
membranes of the distal tubule and the thick ascending limb, respectively. These data are 
validated by the previous western blot analysis (Fig. 3.2B) and strongly support the 
conclusion that the BBMVPCT are essentially free of contaminating apical membranes 
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from non-proximal tubule cells.  The BBMVCTX samples are also significantly enriched 
for meprin, neprilysin, the amino acid transporter: rBAT, glutamine synthetase, and γ-
glutamyltranspeptidase.  
Of particular interest is the identification of neprilysin, which is not expressed in the 
S1 and S2 segments of the proximal tubule [136, 137]. In addition, the amino acid 
transporter, rBAT [138], glutamine synthetase [139], and γ-glutamyltranspeptidase [54] 
are proteins that are primarily expressed in the S3 segment. The increases in rBAT and γ-
glutamyltranspeptidase quantified by spectral counting were confirmed by western blot 
analysis (Fig. 3.9). Thus, the observed increase in their abundance in the BBMVCTX 
further validates the conclusion that the BBMVPCT are derived primarily from the 
proximal convoluted tubule.  
Functional analysis of the proteins that were enriched in the BBMVPCT group revealed 
an increased abundance of enzymes of metabolism and mitochondrial proteins (Fig. 
3.6B). The former group constitutes 39% of the proteins that are significantly enriched, 
but only 19% of the total proteins identified in the BBMVPCT (Fig 3.3B). This group 
contains 11 proteins (Table S1) involved in glucose metabolism including aldolase and 
fructose 1,6-bisphosphatase-1 (Fig. 3.8). Aldolase was previously reported to co-localize 
with the vacuolar H
+
-ATPase in the apical membrane and the submicrovillar zone of 
endocytic vesicles [140]. This interaction is essential for the assembly and the activity of 
the proton pump [141, 142]. Immunofluorescence studies demonstrated that fructose 1,6-
bisphosphatase-1 is also concentrated in the apical region of the rat renal proximal 
convoluted tubule [143]. As a result of their localization, aldolase and fructose - 
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Figure 3.5  Scatter plots of total spectral counts in replicate samples.  Panel A. 
Correlation of total SpC between replicate injections. Pearson’s product indicated a 
correlation of r = 0.97 between typical examples of replicate injections.  Panel B. 
Correlation of total SpC between biological replicates. Pearson’s product indicated 
correlations of r = 0.94 and r = 0.95 between the replicate BBMVCTX and BBMVPCT 
samples, respectively. 
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Figure 3.5  
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Figure 3.6  Statistical analysis of differences in abundance of the proteins identified 
in the BBMVCTX and BBMVPCT samples.  The analysis is illustrated as a plot of log2 of 
the normalized ratio of SpC (RSC) versus the total SpC for all of the identified proteins. 
Solid green and red circles represent proteins increased in either the BBMVPCT or 
BBMVCTX samples, respectively. Open green and red circles represent the proteins from 
the BBMVPCT and BBMVCTX samples that meet only the cutoff of p ≤ 0.001.  Black 
asterisks represent proteins with a p value ≤ 0.01. Solid black circles represent the 
remaining proteins that were not significantly different in the two samples. 
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Figure 3.6 
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Figure 3.7   Functional classification of the proteins that are significantly 
enriched in the BBMVPCT (Panel A) and the BBMVCTX (Panel B) samples.  
 
 
Figure 3.7                                               
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-1,6-bisphosphatase-1 may be trapped in the BBMVPCT that are formed during 
homogenization of isolated proximal convoluted tubules.   The enrichment of multiple 
 enzymes of glucose metabolism also supports the concept that the enzymes form a 
complex that facilitates the channeling of intermediates of glycoylsis and/or 
gluconeogenesis [144]. The positioning of this complex adjacent to the brush border 
membrane may facilitate the catabolism of glucose that is reabsorbed from the glomerular 
filtrate. Alternatively, following an overnight fast [145] or the onset of acidosis [146], 
this complex could facilitate the net renal synthesis of glucose from reabsorbed 
gluconeogenic precursors.  
Mitochondrial proteins constitute 23% of the proteins that are enriched in the 
BBMVPCT but only 11% of total identified proteins. The proteins enriched in the 
BBMVPCT included components of the mitochondrial ATP synthase, including the α, β 
and oligomycin-binding subunits (Fig. 3.8). The mitochondria within the proximal 
convoluted tubule are larger, more elongated, and more abundant than those within the 
proximal straight tubule [116]. In addition, the mitochondria in the S1 and S2 segments 
are positioned in close proximity to the well developed endocytic apparatus immediately 
underneath the brush border membrane. By contrast, the small circular mitochondria 
found in the S3 segment are more evenly distributed throughout the cytosol. As a result, 
mitochondrial proteins, released during homogenization, may be preferentially trapped in 
the BBMVPCT.  
In summary, the reported data establish that sequential isolation of proximal tubules 
by Percoll gradient centrifugation and MgCl2 aggregation yields a highly enriched  
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Figure 3.8  Comparison of the total spectral counts associated with proteins that are 
significantly enriched in the BBMVPCT or BBMVCTX sample.  The total spectral 
counts (SpC) determined for each protein in the BBMVPCT and BBMVCTX samples are 
illustrated by the solid bar and the hatched bar, respectively. The RSC value is the log2 of 
the normalized ratio of the total SpC in the BBMVPCT to the BBMVCTX samples. 
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Figure 3.8 
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Figure 3.9 Validation of the enrichment in BBMVCTX of proteins that are 
preferentially expressed in the S3 segment of the proximal tubule.  Panel A. The 
levels of rBAT and γ-glutamyltranspetidase (γGT) in homogenates of kidney cortex 
(CTX), of isolated proximal convoluted tubules (PCT), and of BBMVCTX and BBMVPCT 
samples were assessed by western blot analysis.  Panel B. The fold enrichment of rBAT 
and γGT in the BBMVCTX to BBMVPCT samples was calculated from the ratio of spectral 
counts (SpC) and by western blot analysis (WB) and illustrated as a bar graph. 
 65
 
 
  Figure 3.9 
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preparation of BBMV that are derived preferentially from the S1 and S2 segments of the 
proximal convoluted tubule.  Comparison of the reported proteomic data to those of 
Cutillas, et al. [82] also indicates that this preparation contains a similar level of 
intracellular contaminants as observed with BBMV purified by capillary free flow 
electrophoresis. However, the reported protocol is simpler and utilizes equipment that is 
more generally available. Thus, the reported protocol and database provide the basis for a 
comprehensive analysis of the temporal changes in the brush border membrane that occur 
in response to various physiological adaptations or pathological conditions.   
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CHAPTER 4 
 
Proteomic Analysis of the Effect of Metabolic Acidosis on the Apical 
Membrane of the Renal Proximal Convoluted Tubule 
 
  
This chapter will be submitted to Molecular and Cellular Proteomics for publication 
Scott J. Walmsley and Norman P. Curthoys 
 
4.1 Abstract 
The physiological response to the onset of metabolic acidosis requires pronounced 
changes in renal gene expression.  Adaptations within the proximal convoluted tubule 
support the increased extraction of plasma glutamine and the increased synthesis and 
transport of NH4
+
 and HCO3
-
 ions and glucose.  Many of these adaptations involve 
proteins associated with the apical membrane.  To quantify the temporal changes in these 
proteins, proteomic analyses were performed using brush border membrane vesicles 
isolated from proximal convoluted tubules (BBMVPCT) that were purified from normal 
and acidotic rats.  This preparation is essentially free of contaminating apical membranes 
from other renal cortical cells.  The analysis identified 298 proteins, 26% of which 
contained one or more transmembrane domains.  Spectral counts were used to assess 
changes in protein abundance.  The onset of acidosis produced a pronounced, but 
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transient, increase in the Na
+
-dependent glucose transporter and a more gradual increase 
in the Na
+
-dependent lactate transporter. These changes were associated with a 
pronounced decrease in the levels of glycolytic and gluconeogenic enzymes contained in 
the isolated BBMVPCT.  In addition, the levels of γ-glutamyltranspeptidase increased 
significantly, while aminopeptidase N and transporters that participate in the uptake of 
neutral amino acids, including glutamine, were decreased.  These changes could facilitate 
the deamidation of glutamine within the tubular lumen.  Finally, pronounced changes 
were also observed in the levels of NHERF3, DAB2, and myosin 6, proteins that 
participate in endocytosis of apical membrane proteins.   
 
4.2 Introduction 
The kidney is a very complex organ that contains multiple nephron segments, each of 
which is composed of one or more unique cell types.  Thus, the coordinate regulation of 
multiple types of cells is required to accomplish the various physiological functions of 
the kidney. Similarly, to mediate the appropriate adaptive response to a physiological or 
pathological stress, such as metabolic acidosis, requires coordinate changes in protein 
expression in multiple cell types [71].  The renal response to metabolic acidosis is 
characterized by an increased extraction and catabolism of plasma glutamine, an 
increased reabsorption and de novo synthesis of bicarbonate ions, and an increased 
synthesis and excretion of ammonium ions that facilitates the excretion of titratable acids 
[147].  This process is initiated in the proximal convoluted tubule which is the primary 
site of glutamine extraction and catabolism [23].  The adaptive responses within the 
proximal convoluted tubule are sustained, in part, by increased expression of the genes 
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that encode the mitochondrial glutamine transporter [148], glutaminase [121, 149] and 
glutamate dehydrogenase [150], the cytoplasmic phosphoenolpyruvate carboxykinase 
(PEPCK1) [19, 151], the apical Na
+
/H
+
 exchanger [152], and the basolateral glutamine 
transporter [37] and Na
+
-3HCO3
-
 co-transporter [152]. The resulting increases in the 
corresponding proteins facilitate the basolateral uptake of glutamine, the increased 
reabsorption of bicarbonate ions, the increased synthesis of ammonium and bicarbonate 
ions, and their vectoral transport across the apical and basolateral membranes, 
respectively.  However, the ultimate excretion of ammonium ions also requires the 
increased expression of the Na
+
K
+
2Cl
-
 co-transporter in the thick ascending limb [66].  
This adaptation facilitates the removal ammonium ions from the tubular fluid and the 
creation of a cortical to medullary gradient.  The ammonium ion gradient provides the 
driving force for the transport of the appropriate amount of ammonium ions across the α-
intercalated cells of the medullary and inner medullary collecting duct [153].  The latter 
process is facilitated by the increased expression of the ammonia channels, RhBG and 
RhCG [154, 155]. 
While the primary renal adaptations to metabolic acidosis are well characterized, 
many questions remain regarding the cellular and molecular mechanisms that mediate 
this response.  Genomic and proteomic approaches offer great potential for directing 
research to answer these questions.  For example, microarray analysis [71] compared the 
mRNAs isolated from whole kidneys of control mice and of mice that were made acidotic 
for 2 d and 7 d.  This analysis detected 13,000 mRNAs or ~ 40% of the genes on the 
mouse genomic array. The levels of 333 mRNAs were up-regulated and another 342 were 
down-regulated during both acute and chronic acidosis.  An even greater number were 
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transiently increased or decreased during onset of acidosis.  Cluster analysis indicated 
that a large proportion of the regulated genes encode solute transporters and proteins 
involved in cell growth, proliferation, apoptosis, ammoniagenesis, water homeostasis, 
and energy metabolism.  Without prior fractionation, it remains uncertain which of the 
observed changes occur within a specific cell type or within multiple segments of the 
nephron.  However, this analysis clearly established that the expression of a very large 
number of genes is altered in the kidney in response to acidosis.  
By contrast, mass spectrometry has been used to profile the proteome of individual 
nephron segments including the proximal convoluted tubule [33], the thick ascending 
limb [156], and the inner medullary collecting duct [157, 158]. Additional proteomic 
analyses have been performed with isolated intercalated cells [159] and with various 
established kidney cell lines [160, 161]. This approach has also been employed to 
discover many of the molecular details of the mechanism by which vasopressin activates 
water [158, 162] and urea transport [163] in the inner medullary collecting duct. An 
initial proteomic analysis of the temporal changes that occur in isolated proximal 
convoluted tubules during onset of acidosis was performed using Difference Gel 
Electrophoresis [33].  This analysis identified 21 proteins which are increased and 16 
proteins that are decreased. The observed changes indicate that amino acid catabolism, an 
ER-stress response, and Ca
++
-signaling are activated, while conversion of glycine to 
creatine, oxidation of pyruvate, and fatty acid catabolism are decreased in the proximal 
convoluted tubule during chronic metabolic acidosis.  The temporal analysis also 
indicated that selective mRNA stabilization may be the primary mechanism by which 
protein expression is increased or sustained in response to acidosis.  
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   Isolation of subcellular fractions from purified nephron segments offers the 
potential to characterize the remodeling of the proteome that occurs within specific sites 
in the cell.  Previous studies have established that brush border membrane vesicles 
isolated from purified proximal convoluted tubules (BBMVPCT) are a highly enriched 
membrane fraction that is essentially free of contaminating apical membranes from other 
cells within the renal cortex [33, 164].  In the current study, this isolation protocol was 
used to perform a proteomic analysis of the temporal changes that occur in the brush 
border membrane of the proximal convoluted tubule during onset of acidosis.   This 
analysis identified 298 proteins and characterized novel adaptations in proteins that 
participate in carbohydrate and amino acid transport and metabolism and in the recycling 
of proteins to and from the brush border membrane. 
 
4.3 Materials and Methods 
4.3a Animals.   
 Male Sprague-Dawley rats weighing ~200 g (8-10 weeks old) were obtained from 
Charles River Laboratories (Kingston, NY).  The rats were allowed free access to a 
rodent chow (Harlan-Teklad, Madison, WI) and the control group (n = 3) was given tap 
water to drink.  To induce acidosis, rats were gavaged with 20 mmol NH4Cl/kg body 
weight and then provided with 0.28 M NH4Cl ab libitum as the sole drinking source.  The 
acidotic groups (n = 3 per group) were treated for 1 d, 3 d, or 7 d before the kidneys were 
excised and processed.  Animals were observed daily to ensure consumption of 0.28 M 
NH4Cl.  All of the acidotic rats consumed a volume of the NH4Cl solution that was 
greater than the amount of water consumed by the control rats. All four groups of rats 
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exhibited similar behavior.  All procedures were approved by the Institutional Animal 
Care and Use Committee at Colorado State University. 
 
4.3b Purification of Proximal Convoluted Tubules 
 Rat renal proximal convoluted tubules were isolated by Percoll density gradient 
centrifugation [164-166]. Briefly, approximately 1 mm
3
 pieces of dissected kidney cortex 
were incubated in phosphate-buffered saline (PBS) containing 5 mM glucose, 1 mg/ml 
bovine serum albumin, 0.1 mg/ml DNAse, 2 mg/ml collagenase B (Roche Diagnostics, 
Mannheim), 1 mM heptanoic acid, 1 mM phenylmethylsulfonyl fluoride, and 1 mM 
sodium orthovanadate.  The resulting nephron segments were washed twice in PBS 
containing 5 mM glucose to remove collagenase and then resuspended in an osmotically 
and pH balanced PBS solution containing 5 mM glucose, 45% Percoll (Sigma Life 
Sciences), and 10 mM Hepes, pH 7.4.  After centrifugation, the tubules were recovered 
from a band that formed near the bottom of the gradient and were washed twice with PBS 
containing 5 mM glucose to remove the Percoll. 
 
4.3c Isolation of Brush Border Membrane Vesicles.  
     Brush border membranes vesicles were prepared from isolated proximal 
convoluted tubules (BBMVPCT) using the standard method of MgCl2 precipitation [80, 
81].  Purified tubules were resuspended in 10 volumes/wet wt. of a solution containing 
300 mM mannitol, 5 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium 
orthovanadate and 12 mM Hepes, pH 7.1.  After Polytron homogenization (90 sec, 
setting 5), the homogenate was diluted 2-fold with H20 and then MgCl2 was added to 
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yield a final concentration of 12 mM.  The mixture was then incubated on ice for 15 min 
with intermittent and gentle mixing.  Following centrifugation at 3,000 x g for 10 min at 
4
o
C to remove mitochondria and cellular debris, the resultant supernatant was centrifuged 
at 30,000 x g for 40 min at 4
o
C to pellet the BBMV.  The pellet was then resuspended in 
1 volume of 150 mM mannitol, 2.5 mM EGTA, and 6 mM Hepes, pH 7.1 and 
homogenized with 15 passes of a glass Teflon homogenizer. The BBMVPCT were again 
precipitated by addition of 12 mM MgCl2 and repetition of the incubation and 
centrifugation steps. The final pellet was resuspended in the previous mannitol buffer and 
the BBMVPCT were stored at -80
o
C. 
 
4.3d  γ-Glutamyltranspeptidase Assay.  
    Aliquots of the cortical homogenates and the isolated BBMVPCT were assayed for 
protein [123] and γ-glutamyltranspeptidase activity [124].  The specific activity 
(µmol·min
-1
·mg
-1
) was determined by quantifying the liberation of p-nitroanaline from 
2.5 mM γ-glutamyl-p-nitroanaline (Sigma-Aldrich) with 20 mM glycylglycine (Sigma-
Aldrich) as the acceptor.   
 
4.3e Sample Preparation and Mass Spectrometric Analysis.   
Aliquots of BBMVPCT containing 100 µg of protein were denatured by heating at 
95
o
C for 5 min. After cooling to room temperature, the samples were dried and 
reconstituted to 3 mg/ml in 7 M urea/2M thiourea. The ultra-sonicated samples were 
reduced (14 mM dithiothreitol, 30 min, 37
o
C), alkylated (7 mM iodoacetamide, 1 h, 
37
o
C), and then diluted 5-fold with 100 mM ammonium bicarbonate, pH 8.0. Sequencing 
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grade modified tryspin (Promega) was added (1:30, enzyme:protein) and the samples 
were incubated for 16 h at 37
o
C.  The peptides were dried (SpeedVac) and reconstituted 
in 30 µl of 0.1% formic acid/3% acetonitrile. Each sample was analyzed in triplicate by 
injecting 1.5 µl aliquots onto an Agilent C-18 reverse phase HPLC Chip (15 µm ID x 1.5 
cm) with a nanospray tip.  Peptides were eluted directly into an Agilent 6520 QTOF mass 
spectrometer using a 22 min linear gradient of 15%-45% acetonitrile in 0.1% formic acid 
at a flow rate of 300 nl/min. MS spectra were collected over an m/z range of 200-2400 
Da.  MS/MS spectra were collected from the triplicate injections using a different data 
dependent acquisition mode for each injection: (1) the 8 most abundant ions in each MS 
scan were selected for MS/MS analysis with no dynamic exclusion limit, (2) the 5 most 
abundant ions in each MS scan were selected using a dynamic exclusion of  3 MS/MS 
spectra of a given mass within an exclusion duration of 20 sec, and   (3) the same 
conditions as (2) but including an exclusion list of the ten most abundant proteins and 
their respective peptides identified in the first two injections.  Compound lists of the 
resulting spectra were generated using Mass Hunter Acquisition 3.2 software (Agilent) 
with an intensity threshold of 1000 and 1 scan/group. 
 
4.3f Bioinformatic analysis.  
       The resulting mass spectra were searched against the Uniprot-KB Rattus norvegicus 
database using SEQUEST and X!Tandem (v.2009.10.01) search engines [90, 125, 126].  
Each search was performed with a mass tolerance of 50 ppm for MS and 0.1 Da for 
MS/MS spectra and with settings for tryptic peptides with up to 2 missed cleavages, with 
carbamidomethylation of cysteine as a fixed modification, and with oxidation of 
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methionine as a variable modification. Peptide false discovery rates (FDR) were 
determined by a target decoy approach using a reversed database concatenated to the 
parent forward database [127, 128]. The results of the searches were combined and the 
identifications were validated using Scaffold v.3.06 (Proteome Software).  Peptide and 
protein  identifications were validated with settings of 95% Peptide Prophet [167], 80% 
Protein Prophet [168], and a minimum precursor mass error of 15 ppm. The use of these 
settings produced a peptide FDR of ≤ 0.1%.  Lists of protein identifications were 
assembled separately for each sample group (Control, 1-d, 3-d, or 7-d acidotic).  An 
additional requirement for protein identification was a minimum of 2 identified peptides 
per protein or the manual verification of a protein identified from a single peptide.  Only 
proteins that were identified in a minimum of 2 biological replicates were included in the 
final list of identified proteins.   
 
4.3g Spectral counting.   
     Spectral counting was used to assess the relative abundance of a protein in each 
sample group [135, 169]. Similarity of sampling across injections and biological samples 
were tested by comparing the spectral counts (SpC) for each injection and each biological 
sample.  Spectral counts for each protein were computed by summing the spectra 
identified using SEQUEST and X!Tandem from each of the three data acquisition modes 
per biological sample.  Principal components analysis and Pearson's test for correlation 
were performed using both the R statistics package (v.2.11.1) (http://www.r-project.org) 
and the Dante v.1.2 software package (http://omics.pnl.gov/software/DAnTE.php) [170] 
to assess and visualize similarity across all the samples, between injections and among 
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each of the biological samples.  Spectral data were compared for variance by analyzing 
the number of proteins identified per sample group, the percent of the total spectra 
identified, and the percent of the total peptides identified. Once the similarity and 
variance between the biological samples were determined, the significance of the 
differences in SpC was calculated 
 
4.3h Cluster analysis and heat maps.   
     SpC data were normalized to the total spectra in each sample and then filtered to 
display proteins which were identified in a minimum of 3 injections per sample group.  
To prevent calculating logarithms of zero, a pseudocount of 1 was added to each SpC of 
the filtered data [103, 132].  The resultant normalized data were then analyzed using the 
Hierarchial clustering function in Dante using an average agglomerative method with a 
Spearman distance matrix.   
 
4.3i Statistical Analysis. 
      Significant changes between the sample groups were calculated using the filtered SpC 
data produced for the cluster analysis.  Student’s t test was used to infer significance of 
differentially expressed proteins.  A  p value  < 0.05 and a minimum of two identified 
peptides per protein were used as the criteria for a significant change in protein 
abundance between the control and each of the acidotic groups. For each protein, the log2 
ratio of the spectral counts (RSC) for the 1-d, 3-d, or 7-d acidotic samples versus the 
control samples was calculated using Eq. 1 [103, 132], where ncontrol and nacidotic are the 
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total spectral counts in the control and acidotic samples, respectively, and t is the total 
spectral counts for all of the identified proteins in each of the two samples.  
(Eq. 1)        
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Once significant differences were determined, the RSC values were plotted versus the total 
spectral counts for each protein in the combined control and acidotic samples. The 
corrected p values were then used to visualize the distribution of the proteins that were 
significantly different in the 1-d, 3-d and 7-d acidotic BBMV sample groups versus the 
control group.  
 
4.3j Enrichment of Functional Annotations.  
     Scaffold files were created separately for each of the control or acidotic groups.  Lists 
of total proteins per sample were tested for enrichment of functional annotations using 
the manually curated Gene Ontology [171] terms within the Scaffold software.   
Functional annotations were selected based on known inferences of cell function (ie., 
brush border membrane, proximal tubule function, glycolysis, etc.). Lists of interest were 
assembled based on these inferences and then expanded by manually evaluating proteins 
whose functional annotations were incomplete.  
 
4.4 Results 
4.4a Purification of Proximal Convoluted Tubules and BBMV.  
 By microscopic inspection, the isolated tubules are > 90% proximal convoluted 
tubules (S1 and S2 segments) with very few proximal straight tubules (S3 segments).  
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The isolated tubules were homogenized and used to isolate BBMVPCT by MgCl2 
precipitation.  Prior to proteomic analysis by liquid chromatography/tandem mass 
spectrometry, the BBMVPCT were assayed for protein and γ-glutamyltranspeptidase 
(γGT) activity, which is expressed primarily in the apical membrane of the S3 segment 
[172].  Similar to our previous study [164, 173], the specific activity of γGT is increased 
only 2-fold in the BBMVPCT compared to the cortical homogenate.  However, the specific 
activity of γGT measured in isolated BBMVPCT gradually increases during onset of 
chronic acidosis (Figure4.1).  The observed 3.2-fold increase in BBMVPCT isolated from 
 7-d acidotic rats is greater than the previous increases reported in whole cortical 
homogenates [174].   
 
4.4b Proteomic analysis of BBMVPCT from control, 1-d, 3-d and 7-d acidotic rats.  
 BBMVPCT were subjected to in-solution digestion and proteomic analysis using a 
QTOF mass spectrometry equipped with a C18-reverse phase HPLC-chip as outlined in 
Figure 4.2A. To increase peptide identifications, precursor ions from triplicate injections 
were selected for collision induced dissociation using three different dynamic acquisition 
methods [175].  The incorporation of an exclusion list in the third dynamic acquisition 
mode increased the number of unique peptides and proteins identified.  Excluding 
peptides from highly abundant proteins, such as megalin (LRP2) and the α-subunit of 
Na
+
/K
+
 ATPase (Na+/K+ ATPase subunit alpha 1), also had the effect of increasing 
spectral counts for the lower abundance proteins (Figure 4.2B).  Spectra were identified 
using both SEQUEST and X!Tandem spectral matching algorithms which further 
increased the spectral assignments per protein.  The false discovery rate (FDR) for the  
 88
 
 
 
Figure 4.1  Onset of acidosis causes an increase in γ-glutamyltranspeptidase activity 
in isolated BBMVPCT.  BBMVPCT were isolated from proximal convoluted tubules that 
were purified from control and acidotic rats and asssayed for γ-glutamyltranspeptidase 
activity (γ-glutamyltranspeptidase) activity and for protein. The fold increase in specific 
activity was calculated relative to the specific activity of the control rats. The data are 
plotted as mean ± S.E. of triplicate samples.  Significance was determined by Student’s t 
test: *p<0.05, **p<0.01. 
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Figure 4.1 
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Figure 4.2.  Work flow for analysis of peptides using a QTOF mass spectrometer.  
Panel A. Proteins were solubilized in 7M urea/2M thiourea, treated to block disulfide 
formation, and subsequently digested with trypsin.  Three data dependent acquisition 
modes (DA mode) were utilized to increase peptide identifications.  The third DA mode 
used an exclusion list of the peptides identified from the ten most abundant proteins as 
determined from the spectral counts acquired in the first two DA modes.  The Venn 
Diagrams illustrate the protein and peptide identifications obtained from each DA mode.  
Panel B.  The highly abundant proteins (LRP2 and Na+/K+ ATPase subunit alpha 1) 
yield fewer spectral counts in DA mode 3, while less abundant proteins produce greater 
spectral counts.  Data are shown for only the control group. 
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Figure 4.2 
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spectral assignments was determined by searching a reverse sequence database 
concatenated to the forward database.  The search parameters used in this study produced 
both a peptide and a protein FDR < 0.1%.  The total number of peptides and proteins 
identified in all four sample groups were 1087 and 298, respectively.  Gene Ontology 
annotations, as edited in Scaffold, were used to identify the functional categories 
represented in the four sample groups (Figure 4.3).  The total number of proteins 
identified per category was similar for each of the sample groups. The largest categories 
of identified proteins included membrane proteins, enzymes of metabolic processes, 
hydrolases and transporters. These annotations are consistent with the physiological 
function of the brush border membrane of the proximal convoluted tubule.   
    Topology predictions (http://www.cbs.dtu.dk/services/TMHMM/) indicated that 80 
proteins, or 26% of the total identified, have a predicted transmembrane domain (TMD).  
Functional categories for the TMD proteins included receptors, peptidases and 
transporters.  In total, 27 transporters with 6 or more TMDs were identified.  The 
functional classification of molecular transport also includes several proteins that 
participate in translocation and membrane insertion of transporters.  The search also 
identified a novel membrane protein, D3ZTX4, which has 1 TMD and is not a 
transporter.  A search for conserved domains using the protein families database 
(http://www.pfam.sanger.ac.uk) indicated D3ZTX4 contained 2 trefoil domains 
(PF00088) that are important for exocellular protection and 2 glycosyl hydrolases 
domains (PF01055) that are functional motifs used to hydrolyze carbohydrate bonds. 
Based upon this sequence homology, the protein was assigned a functional annotation of 
 
 93
 
 
 
Figure 4.3.  Functional classification of proteins identified in control and acidotic 
BBMVPCT samples. The proteins identified in the control, 1-d, 3-d, and 7-d acidotic 
sample groups were classified into selected Gene Ontology annotations using Scaffold 
software.  To better visualize the data, the protein counts were plotted on a log scale. 
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Figure 4.3 
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a O-glycosyl hydrolase (GO:0004553).  Thus, the novel protein may participate in the 
cleavage of di- or trisaccharides prior to transport across the plasma membrane[176].   
The number of proteins identified per sample group, the percent of the total spectra 
identified, and the percent of the total peptides identified were calculated to assess the 
variance between the four sample groups.  The variances, expressed as percent of the 
mean, for all of the assessments were between 5.3% and 22.4%, with the greatest 
deviation occurring in the percent of total peptides identified in the control group.  
However, a heat map illustrating the correlation between spectral counts indicated highly 
correlated biological replicates with an average r value equal to 0.95 (Figure 4.4). The 
samples from the 1-d and 3-d acidotic rats exhibit the greatest correlation (r ≥ 0.98).  The 
two sets of samples differ from the 7-d acidotic samples (r ~ 0.85) and the control 
samples (r < 0.70). 
 
4.4c Quantitative analysis of changes in protein abundance in BBMVPCT during onset 
of acidosis.   
       Since the spectral counts (SpC) for each sample group produced highly correlated 
data sets, spectral counting could be used to assess changes in relative protein abundance 
[104, 177].  Principal components analysis of the data set was performed to compare the 
3 biological replicates within the 4 sample groups (Control, 1-d, 3-d and 7-d acidotic) 
(Supplemental Figure 1A).  The biological replicates grouped in three primary regions of 
the plot.  The 1-d and 3-d samples were found to be most similar to each other, with slight 
overlap.  By contrast, the control and 7-d acidotic samples were significantly different 
from each other and from the 1-d and 3-day acidotic samples.  Further analysis of the  
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Figure 4.4  Correlation of overall proteomic data obtained from control, 1-d, 3-d 
and 7-d acidotic rats.  Heat map of Pearson's correlation data among the 12 biological 
samples (3 per group).   Colors indicate low correlation (r ~ 0.65, blue) to highest 
correlation (r ~ 0.99, red). 
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 Figure 4.4 
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SpC data by hierarchical clustering indicated similar trends in the data (Figure 4.5).  
Several proteins clustered into a group which exhibited a transient decrease in abundance 
during 1 d and 3 d of acidosis, while others decreased rapidly and remained decreased 
even after 7 d.  Fewer proteins exhibited a transient increase during 1 d and 3 d of 
acidosis or increased rapidly and remained increased for 7 d.   
ANOVA was used to determine the statistical significance of the changes in SpC for 
each protein after 1 d, 3 d and 7 d of acidosis compared to the control group. The  data 
were plotted as the log adjusted and normalized ratio of spectral counts (Rsc) versus total 
SpC and color-coded to indicate significant differences (Figure 4.6B).  The plot illustrates 
that it is difficult to validate significant changes in low abundance proteins (< 10 SpC).  
However, significant differences become more evident with increasing abundance.  
Frequently, an arbitrary cutoff of a 2-fold change is used to establish significance for 
proteomic analyses.  However, using this approach it was possible to determine 
significant differences (p < 0.05), which may be less than 2-fold, for each protein 
between each of the acidotic groups and the control samples.  To further illustrate the 
significant differences, the fold change for each protein in each of the acidotic groups was 
calculated relative to the control group and then plotted versus the calculated p value 
(Figure 4.7).  After 1 d of acidosis, 62 of the 298 identified proteins (20.8%) were 
significantly (p ≤ 0.05) increased or decreased (± 1.5-fold).  Most of these proteins 
remain altered in the 3-d acidotic animals.  However, by 7 d of acidosis, nearly half of the 
initially affected proteins have returned to control levels, while a new set of proteins are 
now significantly increased or decreased.  Each of these analyses indicates that the 
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Figure 4.5.  Cluster analysis of the spectral count data. To illustrate trends in the data, 
all 298 proteins were clustered using the Dante software as described in the text.  The 
spectral counts for each protein in the separate samples were expressed relative to the 
mean of the spectral counts for that protein in all the samples.  The results were color 
coded green (below the mean) or red (above the mean) on a log2 scale. 
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Figure 4.5 
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Figure 4.6.  Statistical analysis of spectral count data.  Panel A.  Principal component 
analysis.  A plot of the log2 values of the principle components indicate that the greatest 
differences were observed between the control and the 7-d acidotic groups, whereas the 
1-d and 3-d acidotic samples were the most similar.  Panel B.  Significance analysis.  
Spectral counts were summed for each protein and then plotted versus the Rsc values.  
Colored data points indicate those proteins that were significantly increased (red) or 
decreased (green) versus the control group.  To account for the variance among samples, 
the statistical analysis was calculated using a Student’s t test (p ≤ 0.05) prior to summing 
the spectral counts.   
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Figure 4.6 
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Figure 4.7.  Global analysis of significant changes in protein abundance.  The fold 
change for each protein in each of the 3 acidotic groups was calculated relative to its level 
in the control group and then plotted versus the associated p value.  The proteins that 
were significantly (p ≤ 0.05) increased or decreased (± 1.5-fold) after 1 day of acidosis 
were colored blue (upper panel).  The levels of most of these proteins remain 
significantly altered after 3 d of acidosis (middle panel).  By 7 d of acidosis, most of 
these proteins are no longer significantly different from control values (lower panel).  
However, a new set of proteins now become significantly increased or decreased 
compared to the control levels. 
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Figure 4.7 
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proteome of the brush border membrane of the proximal convoluted tubule undergoes a 
rapid and pronounced remodeling during onset of acidosis.  In addition, each of the 
affected proteins follows one of the limited subsets of temporal patterns.   
Using the Gene Ontology annotations and spectral count data, several transporters 
and other membrane proteins were analyzed for changes in protein abundance (Table 
1A).  Two members of the Na
+
-dependent glucose transporter family, SLC5A2 and 
SLC5A8 were significantly increased in abundance during onset of acidosis.  The apical 
Na
+
-dependent glucose transporter, SLC5A2 (aka SGLT2), is increased nearly 2-fold 
within 1-d and 3-d of onset of acidosis, but returns to normal by 7-d of acidosis.  SGLT2 
is the primary glucose transporter in the apical membrane of the early proximal 
convoluted tubule [178].  By contrast, the apical Na
+
-dependent lactate transporter, 
SLC5A8 (aka SGLT5) [179], is increased more gradually and remains elevated (3-fold) 
even after 7 d of acidosis.  Additional transporters that exhibit less pronounced but 
significant increases include the apical Na
+
-dependent phosphate transporter, SLC34A3 
(aka NaPi2C), and the very abundant basolateral Na
+
/3HCO3
-
 co-transporter, SLC4A4 
(aka NBC-1). By contrast, the Na
+
-dependent phosphate transporter, SLC34A1 (aka 
NaPi2A) is rapidly decreased during onset of acidosis, but returns to normal levels by 3-d 
of acidosis.  The Na
+
/K
+
 ATPase alpha (Na+/K+ ATPase subunit alpha 1) and beta 
(AT1B1) subunits are primarily localized to the basolateral membrane.  The levels of the 
two Na
+
/K
+
 ATPase subunits associated with the BBMVPCT samples were unchanged 
during onset of acidosis (data not shown).  The B, C, E, F and L subunits of the V-type 
H
+
-ATPase (VAT), a known apical marker, were also identified (Table 1A).  Of these, 
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the C and E subunits increased significantly (> 2-fold) by 3 d of acidosis.  By contrast, 
the levels of the B and L subunits were decreased slightly. 
 Proteins identified as having peptidase activity were also quantified (Table 1B). 
Based upon total SpC, dipeptidyl peptidase IV, aminopeptidase N, X-prolyl 
aminopeptidase and γ-glutamyltranspeptidase were the most abundant peptidases. Based 
upon SpC data, γ-glutamyltranspeptidase and glutamyl aminopeptidase were increased 
significantly only after 7 d of acidosis.  However, the dipeptidase, collectrin (TMM27), 
was increased significantly in all of the acidotic samples, but was maximally increased 
(1.9-fold) at 3 d of acidosis.  By contrast, aminopeptidase N decreased significantly in the 
1-d and 3-d aciodtic groups and a soluble dipeptidase (CNDP2) was detected only in the 
control sample.   
Our previous analysis established that BBMVPCT contain significant levels of many of 
the enzymes of glycolysis and gluconeogenesis [164]. Most of these proteins are 
significantly decreased in BBMVPCT isolated from 1-d, 3-d and 7-d acidotic animals 
(Table 2A).  These include fructose-1,6-bisphosphatase and phosphoenolpyruvate 
carboxykinase (PCK1), two enzymes that are unique to gluconeogenesis, and five 
enzymes that catalyze reversible reactions of the glycolytic pathway.  Additional enzymes 
of carbohydrate metabolism that are decreased include transketolase and cytoplasmic 
isoforms of malate dehydrogenase and isocitrate dehydrogenase.  Of this group, only 
Aldolase decreases transiently during 1-d and 3-d of acidosis and then returns to control 
levels.    
     Proteins involved in cytoskeleton structure, membrane scaffolding, vesicle trafficking 
and signal transduction were also analyzed (Table 2B).  NHERF1, NHERF3 and 
 107
PDZKIP1 are known apical markers of the proximal tubule [180].  This group of proteins 
contain PDZ, PDZ interacting, Src homology, or plekstrin homology domains which 
function to target proteins to the apical plasma membrane via their scaffolding 
interactions.  These results, combined with the identification of ezrin, radixin, moesin and 
proteins of the actin filament complex, are consistent with enrichment of BBMVPCT 
[181].  Of these proteins, only myosin 9 was greatly increased (10-fold), while NHERF3 
and PDZK1IP were significantly decreased (2-fold), during early onset of acidosis.  
Identified proteins involved in vesicle trafficking included various isoforms of Rab, Ras 
and Rho, all of which are important for vesicle trafficking and endosomal recycling.  Two 
guanine nucleotide-binding proteins, the alpha-2 subunit of Gi  and the beta-2 subunit of 
Gi/Gs/Gt were also observed.  Both are membrane-associated proteins that are GTP-
dependent modulators of signal transduction.  Sequence annotation from uniprot.org 
suggests that Gi alpha-2 subunit may function as a MAP-Kinase-Kinase activator.  Of 
these proteins, only Rab1A and Rab7A exhibit transient decreases during onset of 
acidosis. 
 
4.5 Discussion 
4.5a  Proteins involved in carbohydrate transport and metabolism.   
        During metabolic acidosis, the kidney becomes an important gluconeogenic organ. 
The initial conversion of glutamine to α-ketoglutarate generates 2 NH4
+
 ions.  In rats 
[182, 183] and humans [145], the α-ketoglutarate generated from the renal catabolism of 
glutamine is primarily converted to glucose.  This process requires the cataplerotic 
activity of phosphoenolpyruvate carboxykinase to convert intermediates of the 
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tricarboxylic acid cycle to phosphoenolpyruvate.  This pathway generates 2 H
+
 and 2 
HCO3
-
 ions per α-ketoglutarate.  The 2 H
+
 ions are subsequently consumed during the 
conversion of phosphoenolpyruvate to glucose.  Therefore, the combined pathways of 
ammoniagenesis and gluconeogenesis result in a net production of 2 HCO3
-
 per 
glutamine, which are transported into the renal venous blood.  As a result, the combined 
adaptations create a net renal release of HCO3
-
 ions that partially restore acid-base 
balance.  This process is activated, in part, by the rapid and pronounced (7-fold) increase 
in phosphoenolpyruvate carboxykinase that occurs within the proximal convoluted tubule 
[33, 151].  
Previous proteomic analysis established that enzymes of glycolysis and 
gluconeogenesis are enriched in BBMVPCT compared to BBMV isolated from renal 
cortex [164].  The latter preparation contains apical membranes from multiple cortical 
cells in addition to the proximal convoluted tubule.  The observed enrichment suggests 
that during normal acid-base balance enzymes of glucose metabolism may form a 
complex that is sequestered near or associated with the brush border membrane of the 
proximal convoluted tubule.  Previous immunofluorescence studies have clearly 
established that aldolase [140] and fructose 1,6-bisphosphatase [143] are normally 
localized to the apical membrane of the proximal convoluted tubule[142]. Similar 
observations in erythrocytes[184] suggested that the association of the enzymes of 
glycolysis with the membrane may generate a higher localized concentration of ATP that 
is used to support active transport processes [184].  The finding that several proteins 
involved in the reversible steps of glycolysis and in gluconeogenesis are significantly 
decreased or no longer detectable in BBMVPCT isolated from acidotic rats suggests that 
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the sequestered complex may dissociate from the apical membrane during acidosis. The 
release of enzymes, including fructose-1,6-bisphosphatase and phosphoenolpyruvate 
carboxykinase, may support the rapid increase in glucose synthesis [145].  The selective 
return of aldolase to the brush border membrane following 7 d of acidosis may be due to 
its functional association with the A, B, and E subunits of the V-type H
+
-ATPase [140].  
Previous studies have clearly established that aldolase co-localizes with the H
+
-ATPase 
and that this interaction is essential for the membrane insertion and correct assembly of 
the H
+
-ATPase [141].  Thus, the transient decrease in aldolase may contribute to the 
altered ratios of H
+
-ATPase subunits that are observed during onset of acidosis. 
The observed transient increase in the Na
+
-dependent glucose transporter (SGLT2) 
was confirmed by western blot analysis. This finding suggests that a greater proportion of 
the filtered glucose may be reabsorbed within the early proximal convoluted tubule 
during onset of acidosis.  The reabsorbed glucose could provide energy to support the 
pronounced remodeling of the cellular proteome that occurs during early onset of 
acidosis. However, given the rapid and pronounced shift towards gluconeogenesis, it is 
more likely that the reabsorbed glucose undergoes transepithelial transport and is 
returned to the blood.  Finally, the gradual increase in the Na
+
-dependent lactate 
transporter (SGLT5) suggests lactate may become a more important metabolic fuel or 
gluconeogenic precursor in the proximal convoluted tubule during prolonged metabolic 
acidosis.  
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4.5b Cytoskeletal, scaffolding and trafficking proteins.  
       Scaffolding proteins within the apical projections of the proximal convoluted tubule 
play an important role in the insertion and recycling of brush border membrane proteins 
[181].  The PDZ domain containing proteins, NHERF1 and NHERF3, were quantified in 
our analysis (Table 2B).  NHERF1 was originally identified as a protein kinase A 
dependent modulator of the apical Na
+
/H
+
-exchanger (NHE3) activity [185]. However, it 
is now known that NHERF1 interacts with multiple membrane proteins including CLC3, 
SLC34A1, Gi/Gs/Gt Guanine nucleotide binding protein complex and H
+
-ATPase [181].  
NHERF1 also interacts with the ezrin-radixin-moesin complex that binds to actin.  These 
interactions contribute to the targeting of vesicles and the insertion of proteins into the 
apical membrane.  Therefore, changes in this class of proteins could contribute to the 
pronounced remodeling of the brush border membrane that occurs during onset of 
acidosis.  Several of these proteins were identified in our analysis.  However, total SpC 
detected for many of these proteins were not as pronounced as other classes of proteins.  
As a result, the observed increase in NHERF1 was not statistically significant. However, 
the transient decreases observed for the more abundant NHERF3 and the adapter protein, 
DAB2, were significant.  The most significant change was the pronounced increase (10-
fold) in myosin 6.  This isoform of myosin functions to move proteins along actin 
filaments from the body to the base of the microvilli of the proximal tubule [186].  
Recent experiments using TIRF microscopy and a dominant negative form of myosin 6 in 
opossum kidney cells demonstrated that this isoform participates in the parathyroid 
hormone-stimulated removal of NaPi2 from the apical membrane [187].  Therefore, the 
observed increase in myosin 6 levels in BBMVPCT isolated from acidotic rats suggests 
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that it may also contribute the pronounced remodeling of the apical membrane during 
onset of acidosis. 
Rab proteins also participate in the recycling of membrane proteins.  We identified 
two isoforms, Rab5c and Rab7, that are known regulators of endocytosis from apical 
clathrin coated pits [188, 189].  Clathrin levels were significantly increased, while Rab5c 
and Rab7 were either not detected or transiently decreased, respectively, during 1-d and 
3-d of acidosis. Many of the additional Rab proteins have low SpC compared to the 
proteins that are specific to the apical membrane. These proteins are probably associated 
with endosomes that are trapped in the vesicles during homogenization. 
 
4.5c Amino acid transport and metabolism.   
        The observed increase in γ-glutamyltranspeptidase (γGT) was confirmed by 
enzymatic assay.  This enzyme also catalyzes a phosphate-independent glutaminase 
activity [122]. In normal rats, γGT is expressed primarily on the luminal surface of the 
proximal straight tubule [54, 172], which contains little glutamine [23]. However, the 
observed increase in γGT in BBMVPCT suggests that during acidosis, it may facilitate the 
deamidation of filtered glutamine within the lumen of the proximal convoluted tubule.  
This process would be enhanced by the observed transient decreases in rBAT and B
o
AT1, 
which are apical neutral amino acid transporters that facilitate glutamine uptake [24].   
 
4.5d Relevance to brush border membrane physiology.   
        Proteomic analyses are typically completed for two purposes, the identification of 
proteins in a particular sample and the quantification of changes in protein abundance.  In 
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this study, the inclusion of multiple dynamic acquisition modes increased the number of 
proteins that were confidently identified in the BBMVPCT samples.  In addition, statistical 
analyses of spectral counts were used to provide an initial assessment of the changes in 
protein abundance that occur during onset of metabolic acidosis.  A large proportion of 
the identified proteins exhibit transient increases or decreases, while a smaller number of 
proteins exhibit changes that are sustained even after 7 d of acidosis.  Some of the 
observed changes were confirmed by western blot analysis and shown to involve even 
greater changes than assessed by spectral counting.  Not all of the observed changes were 
discussed in this manuscript.  Thus, researchers are encouraged to peruse the complete 
data set given in Supplemental Table 1 to determine if their protein of interest may 
respond to metabolic acidosis.  In the future, targeted proteomic analyses will be 
performed to further validate the observed changes and to develop testable hypotheses for 
biochemical and immunofluorescence studies. 
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Table 1
A. Transporters, phosphatase, peptidase Gene_Symbol Mass TMD SpC Functional Category
Protein (Uniprot) (kDa) (TMHMM) C ±SE 1 Day ±SE 3 Day ±SE 7 Day ±SE Subclass Apical?
Excitatory amino acid transporter 3  
GN=Slc1a1  
EAA3_RAT 57 9 5.7 1.3 3.7 2.2 4.7 2.0 10.3 1.2 dicarboxylic acid Y
Neutral and basic amino acid transport 
protein rBAT  GN=Slc3a1  
SLC31_RAT 79 1 28.7 6.2 11.3 3.2 13.0 5.3 25.3 3.2 amino acid Y
4F2 cell-surface antigen heavy chain  
GN=Slc3a2  
4F2_RAT 58 1 43.3 4.1 22.3 6.1 24.7 2.9 34.0 7.9 neutral amino acid Y
Electrogenic sodium bicarbonate 
cotransporter 1  GN=Slc4a4  
S4A4_RAT 121 9 23.0 2.5 24.7 6.9 33.0 1.5 39.0 4.6 bicarbonate ion -
Sodium/glucose cotransporter 1  GN=Slc5a1  SC5A1_RAT 73 14 2.7 1.2 1.0 0.0 1.3 0.3 1.7 0.7 carbohydrate Y
Sodium/glucose cotransporter 2  GN=Slc5a2  SC5A2_RAT 73 14 21.0 0.6 38.7 1.2 38.3 4.1 20.3 0.9 carbohydrate Y
Putative uncharacterized protein Slc5a8  
GN=Slc5a8  
D3Z9E5_RAT 66 13 5.3 0.9 8.7 1.5 20.3 0.3 16.7 1.9 neurotransmitter Y
Slc5a10 protein  GN=Slc5a10  B1WBS5_RAT 59 13 3.3 1.9 1.0 0.0 1.0 0.0 8.3 1.5 transmembrane Y
Sodium- and chloride-dependent creatine 
transporter 1  GN=Slc6a8  
SC6A8_RAT 71 12 3.7 1.5 1.0 0.0 1.0 0.0 1.0 0.0 creatine Y
Transporter  GN=Slc6a18  S6A18_RAT 66 12 3.0 1.0 3.7 0.9 9.7 0.7 1.0 0.0 neurotransmitter Y
Transporter  GN=Slc6a19  S6A19_RAT 57 12 13.0 1.5 15.7 4.2 15.7 3.8 6.3 0.9 neutral amino acid Y
Monocarboxylate transporter 1  
GN=Slc16a1  
MOT1_RAT 53 11 1.3 0.3 1.3 0.3 1.0 0.0 1.0 0.0 monocarboxylate Y
Putative uncharacterized protein Slc22a1  
GN=Slc22a1  
S22A1_RAT 62 12 2.0 0.0 1.0 0.0 1.0 0.0 1.7 0.7 organic cation -
Putative uncharacterized protein Slc22a6  
GN=Slc22a6  
S22A6_RAT 60 8 11.0 1.0 8.3 0.9 11.7 1.2 11.3 0.3 organic anion -
Solute carrier family 22 member 8  
GN=Slc22a8  
S22A8_RAT 59 9 3.3 1.9 1.0 0.0 1.3 0.3 4.3 2.0 quaternary ammonium -
Solute carrier family 22 member 12  
GN=Slc22a12  
S22AC_RAT 60 10 1.0 0.0 1.0 0.0 1.0 0.0 1.7 0.7 urate Y
Mitochondrial dicarboxylate carrier 
GN=SLC25a10
O89035_RAT 31 0 1.0 0.0 4.7 2.3 5.0 1.0 2.7 1.7 malate -
Sodium-dependent phosphate transport  
protein 2A  GN=Slc34a1  
NPT2A_RAT 69 11 11.0 6.5 4.3 0.3 8.0 2.1 9.0 0.6 phosphate Y
Sodium-dependent phosphate transport  
protein 2C  GN=Slc34a3  
NPT2C_RAT 64 11 3.3 0.9 5.7 0.7 7.7 1.9 4.7 1.9 phosphate Y
Aquaporin-1  GN=Aqp1  AQP1_RAT 29 6 9.3 0.3 8.0 3.1 8.7 0.9 14.0 1.2 Glycerol, water Y
ATP-binding cassette sub-family G member 
2  GN=Abcg2  
ABCG2_RAT 73 6 1.3 0.3 1.7 0.7 1.3 0.3 4.0 1.0
drug transmembrane 
activity
Y
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Solute carrier family 22 member 12  
GN=Slc22a12  
S22AC_RAT 60 10 1.0 0.0 1.0 0.0 1.0 0.0 1.7 0.7 urate Y
Mitochondrial dicarboxylate carrier 
GN=SLC25a10
O89035_RAT 31 0 1.0 0.0 4.7 2.3 5.0 1.0 2.7 1.7 malate -
Sodium-dependent phosphate transport  
protein 2A  GN=Slc34a1  
NPT2A_RAT 69 11 11.0 6.5 4.3 0.3 8.0 2.1 9.0 0.6 phosphate Y
Sodium-dependent phosphate transport  
protein 2C  GN=Slc34a3  
NPT2C_RAT 64 11 3.3 0.9 5.7 0.7 7.7 1.9 4.7 1.9 phosphate Y
Aquaporin-1  GN=Aqp1  AQP1_RAT 29 6 9.3 0.3 8.0 3.1 8.7 0.9 14.0 1.2 Glycerol, water Y
ATP-binding cassette sub-family G member 
2  GN=Abcg2  
ABCG2_RAT 73 6 1.3 0.3 1.7 0.7 1.3 0.3 4.0 1.0
drug transmembrane 
activity
Y
Collectrin GN=Tmem27 TMM27_RAT 25 1 14.7 1.8 26.3 1.7 28.3 3.0 23.3 0.3 peptidyl-dipeptidase activity Y
V-type proton ATPase subunit  B, brain 
isoform  GN=Atp6v1b2 
VATB2_RAT 57 - 50.7 1.3 40.3 2.4 34.7 4.5 47.7 7.8 ATPase Y
V-type proton ATPase subunit  C 1  
GN=Atp6v1c1 
VATC1_RAT 44 - 11.7 2.7 23.7 3.2 26.7 0.7 5.3 1.3 ATPase Y
V-type proton ATPase subunit  E 1  
GN=Atp6v1e1 
VATE1_RAT 26 - 15.3 0.9 32.3 2.0 33.3 4.5 22.7 2.3 ATPase Y
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Table 1
B. Peptidase, phosphatase Gene_Symbol Mass TMD SpC
Protein (Uniprot) (kDa) (TMHMM) C ±SE 1 Day ±SE 3 Day ±SE 7 Day ±SE
Alkaline phosphatase, t issue-nonspecific 
isozyme GN=Alpl 
PPBT_RAT 58 - 8.7 0.9 9.7 0.9 8.0 3.2 11.0 3.2 Protein Phosphatase Y
Protein phosphatase 2 (Formerly 2A), 
regulatory subunit A (PR 65), alpha isoform, 
isoform CRA_a GN=Ppp2r1a 
Q5XI34_RAT 65 - 1.3 0.3 1.3 0.3 1.0 0.0 1.0 0.0 Protein Phosphatase -
Aminopeptidase N GN=Anpep AMPN_RAT 109 1 94.0 5.5 41.7 4.3 53.3 6.9 87.3 8.2 Serine-type peptidase Y
Dipeptidyl peptidase 4 GN=Dpp4 DPP4_RAT 88 1 59.3 2.8 35.0 8.5 35.0 6.4 64.7 4.7 Aminopeptidase Y
Membrane-bound aminopeptidase P 
GN=Xpnpep2 
Q99MA2_RAT 76 - 47.0 2.6 26.3 3.0 38.0 6.0 45.3 4.1 Metallo exopeptidase Y
Gamma-glutamyltranspeptidase 1 GN=Ggt1 GGT1_RAT 62 1 26.0 2.0 14.3 2.7 15.7 2.4 44.0 2.6 Acyltransferase Y
Glutamyl aminopeptidase GN=Enpep AMPE_RAT 108 1 24.0 5.6 13.3 1.3 13.0 2.9 14.7 3.8 Aminopeptidase Y
Dipeptidase 1 GN=Dpep1 DPEP1_RAT 46 - 7.0 1.5 7.0 3.5 14.7 9.1 5.3 0.7 Dipeptidase Y
Cytosolic non-specific dipeptidase 
GN=Cndp2 
CNDP2_RAT 53 - 8.0 1.0 1.0 0.0 1.0 0.0 1.0 0.0 Carboxypeptidase -
Retinoid-inducible serine carboxypeptidase 
GN=Scpep1 
RISC_RAT 51 1 5.3 2.3 1.0 0.0 1.0 0.0 1.0 0.0
Serine type 
carboxypeptidase
-
Xaa-Pro dipeptidase GN=Pepd PEPD_RAT 55 - 2.7 1.2 1.0 0.0 1.0 0.0 1.0 0.0 Metallo exopeptidase Y
Glutamate carboxypeptidase 2 GN=Folh1 FOLH1_RAT 85 1 4.7 1.2 2.7 0.7 7.0 3.5 13.3 3.0 Metalloprotease -
Xaa-Pro aminopeptidase 1 GN=Xpnpep1 XPP1_RAT 70 - 2.0 0.0 1.0 0.0 1.0 0.0 1.0 0.0
Metalloamino 
peptidase
Y
Dipeptidyl peptidase 2 GN=Dpp7 DPP2_RAT 55 - 1.7 0.3 1.0 0.0 1.0 0.0 1.0 0.0 Serine-type peptidase -
Low-density lipoprotein receptor-related 
protein 2 GN=Lrp2 
LRP2_RAT 519 1 147.0 7.0 122.3 6.4 112.7 4.3 126.3 6.6
Receptor, SH3 domain 
binding
Y
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Table 2 
A. Carbohydrate Metabolic Process Gene_Symbol  Mass SpC KEGG 
Protein (Uniprot) (kDa) Control ±SE 1 Day ±SE 3 Day ±SE 7 Day ±SE 
Functional 
Category ID  
Phosphoenolpyruvate 
carboxykinase, cytosolic [GTP] 
GN=Pck1 
PCKGC_RAT 69 8.0 3.6 1.3 0.3 1.0 0.0 5.0 1.2 gluconeogenesis rno00010 
Glycolysis/ 
gluconeogenesis 
L-lactate dehydrogenase B chain  
GN=Ldhb   
LDHB_RAT 37 30.7 3.3 7.0 1.0 6.5 1.2 3.3 1.2 glycolysis rno00010 
Glycolysis/ 
gluconeogenesis 
Malate dehydrogenase, 
cytoplasmic  GN=Mdh1   
MDHC_RAT 36 22.7 3.9 1.0 0.0 1.0 0.0 1.0 0.0 glycolysis rno00620 
Pyruvate 
metabolism 
Enolase GN=Eno1 Q5EB49_RAT 47 50.3 4.2 1.7 0.3 2.0 0.8 4.3 2.3 glycolysis rno00010 
Glycolysis/ 
gluconeogenesis 
Glyceraldehyde-3-phosphate 
dehydrogenase  GN=Gapdh   
Glyceraldehyde-3-phophate dehydrogenase_RAT 36 51.3 3.7 1.7 0.3 4.0 0.0 20.3 1.7 
gluconeogenesis 
/ glycolysis 
rno00010 
Glycolysis/ 
gluconeogenesis 
Fructose-bisphosphate aldolase  
GN=Aldob   
Q66HT1_RAT 40 71.0 4.0 24.0 4.2 27.5 1.2 60.0 8.2 glycolysis rno00010 
Glycolysis/ 
gluconeogenesis 
Fructose-1,6-bisphosphatase 1  
GN=Fbp1   
F16P1_RAT 40 80.7 1.9 14.0 3.6 23.0 4.1 12.3 6.6 gluconeogenesis rno00010 
Glycolysis/ 
gluconeogenesis 
Glucose-6-phosphate isomerase 
GN=Gpi 
G6PI_RAT 63 15.0 3.1 1.0 0.0 1.5 0.4 2.3 0.3 
gluconeogenesis 
/ glycolysis 
rno00010 
Glycolysis/ 
gluconeogenesis 
Transketolase  GN=Tkt   TKT_RAT 68 24.7 5.0 1.0 0.0 1.0 0.0 4.3 2.8 
pentose-
phosphate shunt 
rno00030 
Pentose 
phosphate 
pathway 
Triosephosphate isomerase 
GN=LOC500959 
Q6SA19_RAT 27 9.3 0.3 1.0 0.0 1.0 0.0 1.0 0.0 glycolysis rno00010 
Glycolysis/ 
gluconeogenesis 
Isocitrate dehydrogenase [NADP] 
cytoplasmic  GN=Idh1   
IDHC_RAT 47 14.7 3.5 1.0 0.0 1.0 0.0 1.0 0.0 glyoxylate cycle rno00480 
Glutathione 
metabolism 
Putative uncharacterized protein 
Ogdh  GN=Ogdh   
D3ZFA6_RAT 118 1.0 0.0 8.0 1.2 4.5 2.0 2.0 0.6 
carbohydrate 
metabolic 
process 
- - 
Putative uncharacterized protein 
ENSRNOP00000016912    
D3ZTX4_RAT 197 18.7 0.7 12.3 2.0 19.0 0.0 17.7 7.9 
carbohydrate 
metabolic 
process 
- - 
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Table 2
B. Signal transduction, Trafficking, Cytoskeleton SpC PFAM PFAM
Protein Gene_Symbol (kDa) Control ±SE 1 Day ±SE 3 Day ±SE 7 Day ±SE Functional CategoryDomain or family ID
Ras-related protein Rab-1A  GN=Rab1A  RAB1A_RAT 23 8.0 0.6 1.7 0.3 9.3 1.9 6.7 1.5
protein transport, small 
GTPase mediated signal 
Ras PF00071
Ras-related protein Rab-1B  GN=Rab1b  RAB1B_RAT 22 1.0 0.0 1.0 0.0 1.0 0.0 1.7 0.7
protein transport, small 
GTPase mediated signal 
Ras PF00071
RCG32615, isoform CRA_a  GN=Rab5c  B0BNK1_RAT 23 3.0 1.2 1.0 0.0 1.0 0.0 4.3 2.0
protein transport, small 
GTPase mediated signal 
Ras PF00071
Ras-related protein Rab-7a  GN=Rab7a  RAB7A_RAT 24 10.7 0.9 3.0 1.0 6.7 1.3 15.0 4.4
protein transport, small 
GTPase mediated signal 
Ras PF00071
Putative uncharacterized protein Rab8a  
GN=Rab8a  
D3Z848_RAT 24 0.3 1.7 0.3 1.3 0.3 1.3 0.3
protein transport, small 
GTPase mediated signal 
Ras PF00071
RAB10, member RAS oncogene family  
GN=Rab10  
Q5RKJ9_RAT 23 2.7 0.7 3.0 1.0 2.0 1.0 5.0 2.3
protein transport, small 
GTPase mediated signal 
Ras PF00071
Ras-related protein Rap-1A  GN=Rap1a  RAP1A_RAT 21 9.7 0.3 13.7 2.8 11.3 1.9 8.3 1.7
protein transport, small 
GTPase mediated signal 
Ras PF00071
RCG40097 OS=Rattus norvegicus GN=Rras2 Q5BJU0_RAT 23 2.0 0.6 2.3 0.9 1.7 0.7 1.7 0.3
protein transport, small 
GTPase mediated signal 
Ras PF00071
Guanine nucleotide-binding protein G(i) subunit 
alpha-2 GN=Gnai2
GNAI2_RAT 41 1.0 0.0 1.0 0.0 1.0 0.0 2.3 0.7
signal transducer 
activity
WD40 PF00400
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2  GN=Gnb2 
GBB2_RAT 37 1.3 0.3 1.7 0.3 1.0 0.0 2.7 1.7
signal transducer 
activity
G-alpha PF00503
Na(+)/H(+) exchange regulatory cofactor NHE-
RF1  GN=Slc9a3r1 
NHRF1_RAT 39 8.7 2.7 5.7 1.2 9.7 1.5 14.7 6.1 PDZ Domain containing PDZ PF00595
Na(+)/H(+) exchange regulatory cofactor NHE-
RF3  GN=Pdzk1
NHRF3_RAT 57 47.7 14.8 32.3 11.0 49.7 6.2 35.0 9.5 PDZ Domain containing PDZ PF00595
Putative uncharacterized protein 
ENSRNOP00000048147 DAB2 similar
D3ZGX5_RAT 49 15.7 1.8 6.0 1.5 10.0 2.1 22.7 2.4 PDZ Interacting PTB/PIC PF00640
PDZK1-interacting protein 1  GN=Pdzk1ip1 PDZ1I_RAT 12 4.7 3.2 6.0 2.9 14.0 1.5 8.7 2.6 Protein binding - -
Alpha II spectrin  GN=Spna2 C9EH87_RAT 288 3.3 0.9 11.7 3.9 13.3 3.3 12.3 5.5 protein complex binding SH3_1 PF00018
Non-erythroid spectrin beta  GN=Sptbn1 Q6XD99_RAT 274 1.3 0.3 5.0 0.6 4.0 1.7 11.7 5.8 actin binding CH , PH PF00307,  PF00169
Mitogen-activated protein kinase scaffold protein 
1  GN=Mapksp1
MPKS1_RAT 14 4.3 1.3 1.7 0.3 2.0 0.6 5.7 0.9 Protein binding MAPKK1_Int PF08923
Actin, cytoplasmic 1  GN=Actb  ACTB_RAT 42 56.7 10.2 74.0 4.5 75.7 7.8 68.0 12.8 actin cytoskeletal Actin PF00022
Actin-related protein 3  GN=Actr3  ARP3_RAT 47 3.7 0.9 2.0 1.0 1.0 0.0 2.0 1.0 actin binding Robl_LC7 PF03259
Alpha-actinin-4  GN=Actn4  ACTN4_RAT 105 23.7 5.0 28.7 3.7 25.7 1.5 23.7 9.2 actin cytoskeletal CH,efhand PF00307,PF00036
Programmed cell death 6-interacting protein 
GN=Pdcd6ip
PDC6I_RAT 97 1.7 0.3 1.0 0.0 1.0 0.0 1.0 0.0 Protein Binding Bro1 PF03097
Ezrin  GN=Ezr  EZRI_RAT 69 52.7 6.3 32.3 3.0 52.7 4.7 63.7 6.9 actin filament 
FERM_C,FE
RM_M, 
PF09380, PF00373, 
PF09379
Radixin  GN=Rdx  Q5PQK5_RAT 69 16.3 4.8 14.7 1.8 18.7 1.8 10.0 2.5
cytoskeletal protein 
binding
FERM_C,FE
RM_M,FER
PF09380, PF00373, 
PF09379
Moesin  GN=Msn  MOES_RAT 68 8.3 3.5 1.7 0.7 2.3 0.7 5.3 4.3 actin binding
FERM_C,FE
RM_M,FER
PF09380, PF00373, 
PF09379
Myosin-9  GN=Myh9  MYH9_RAT 226 1.7 0.3 10.3 0.9 8.0 1.5 12.7 5.0
actin filament based 
movement
IQ PF00612
Myl6 protein  GN=Myl6  B2GV99_RAT 17 4.3 0.3 3.0 1.0 3.7 1.2 5.7 1.2 motor activity efhand PF00036
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CHAPTER 5 
 
 
Validation by AMT and LC-MS Mass Spectrometry 
 
 
5.1 Introduction 
 Accurate mass and time tag  (AMT) technology was originally developed for the 
identification and quantitation of peptides by LC-MS using high mass accuracy mass 
spectrometers[112, 190].  LC-MS identification of peptides are matched to a database of 
high quality peptide identifications based on their mass and reproducible normalized 
retention time as determined using  C18 reversed phase chromatography.   Typically, this 
method utilized orbitrap or fourier transform ion cyclotron resonance (FTICR) mass 
spectrometers.   Mass accuracy of these instruments are  ±0.1ppm to 1 ppm mass error for 
both MS and CID spectra.  The AMT matching of the LC-MS eluted and subsequently  
detected peptides to a database of “tags” was dependent on two primary parameters: 1) 
the mass accuracy of the instrument, and 2) the reproducibility of the retention time (RT) 
for the charged peptides that are detected with the mass spectrometer.  The 
reproducibility of the RT for each peptide is dependent on its sequence [191]. 
 Due to the complexity of a typical sample from whole cell lysate and due to the 
mass accuracy of the instrument, it is difficult to identify a precursor peak solely using 
mass or RT.  Such an ability is dependent on the theoretical mass distribution of peptides 
produced in a typical trypsin treated sample.  For a complex sample, in order to  obtain 
 119
the statistical confidence of identification by AMT analysis, a very high mass accuracy 
mass spectrometer is required. Such instruments are beyond the fiscal capabilities of a 
typical laboratory. 
 The quadrupole time of flight (QTOF) mass spectrometer is an instrument more 
common in laboratories.   The QTOF offers a mass accuracy of ± 5 ppm (or less) of the 
selected precursor ions.  These parameters are ideal when combined with samples that 
have reduced  complexity as produced by subcellular fractionation.  This, together with  
predictable and specific trypsin activity can result in a robust platform for AMT based 
identification of LC-MS peptide features.    
 In this chapter, we describe an adaptation of  the AMT methods based on our 
spectral counting data in Chapter 3 and Chapter 4 [173].  Using the SpC identifications 
from our previous two studies,  selected markers of acidosis from PCT brush border 
membrane vesicles were identified by AMT and then the abundances were validated 
using the more accurate peak intensity measurements.  The differential LC-MS analysis 
produced high quality abundance data. The peptide abundances were combined to 
produce protein level quantification.  Selected markers of MA were profiled and 
positively correlated with the spectral count data (R
2
=0.71-0.88).  Of these, enolase A, 
fructose 1,6- bisphosphatase and glyceraldehyde-3,4-phophate dehydrogenase were 
significantly reduced in BBMV during 1-d,3-d and 7-d MA. Additionally, the Na
+
-
facilitated glucose transporter 2 (SGLT2) increased  during 1-d and 3-d MA.  The altered 
abundances of the enzymes of glucose metabolism together with altered abundance of 
SGLT2 indicated a remodeling of these proteins to aid in the PCT response to MA. 
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5.2 Materials and Methods 
5.2a Materials  
 Aliquots of the same BBMV samples used in chapter 4 were set aside for analysis 
by LC-MS and AMT.  The methods of sample preparation for mass spectrometry  are 
outlined in the Methods in section 4.3 of chapter 4.  Data files used for the AMT database 
preparation are from the same analysis produced in the spectral counting study.  
 
5.2b AMT Database preparation 
 Using the spectra identified in chapter 4, the individual X!Tandem [125] result 
files were combined by group and then the AMT database was built.  Individual  
databases grouped by condition were assembled using the msInspect v2.3 --createamt 
command with the default settings and using a minimum PeptideProphet score of 
0.9[109, 167]. A curated protein fasta database containing every protein identified in our 
SpC analysis was used for building the AMT database.  The individual AMT databases 
were then combined and then non linear aligned with the default settings.  
 
5.2c  LC-MS analysis 
  Each sample was analyzed in triplicate by injecting 0.25 µl aliquots onto an 
Agilent C-18 reverse phase HPLC Chip (15 µm ID x 1.5 cm) with a nanospray tip.  
Peptides were eluted directly into an Agilent 6520 QTOF mass spectrometer using a 22 
min linear gradient of 15%-45% acetonitrile in 0.1% formic acid at a flow rate of 300 
nl/min. MS spectra were collected over an m/z range of 200-3000 Da.    Data was 
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collected in profile mode and then the raw data files converted to mzXML format using 
Trapper v4.3.1 with a custom Perl script. 
 
5.2d LC-MS peptide feature finding and matching to the AMT database 
 LC-MS features from each replicate were identified separately using the 
findpeptides mode of msInspect v2.3 with the walksmoothed parameter.  Features were 
filtered so that only MS peaks with two or more monoisotopic peaks were included in the 
analysis.   The MS peaks in each separate LC-MS feature file  were then matched to the 
AMT database. This was accomplished by using the LC-MS mzXML files for retention 
time information together with the loosedeltamass=100ppm and loosedeltaelution=.30 
parameters.   After matching each file to the AMT database, individual match files were 
aligned using the the peptidearray function with the alignbytags=loose parameter.   
 
5.2e  Quantitation of relative abundance changes 
 The peptide array containing the aligned and AMT matched features from the 
replicate datasets were analyzed for differential changes in abundance.  The log 2 
adjusted data were Loess normalized using DanteR v0.1.1[170].  To determine 
significance, the altered abundances were analyzed using ANOVA at both the level of the 
peptide and protein in separate analysis.  PCA and volcano plots were created using 
DanteR. 
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5.2f Additional Statistical  analysis 
 Peptide uniqueness statistics and normalized retention time (NRT) predictions 
were analyzed using the Sequence Specific Retention Time Calculator v3.0  
(http://hs2.proteome.ca/SSRCalc/SSRCalcHelp.htm)  (gradient delay time of 0.1 min, 
slope = 0.35) and the Protein Digestion Simulator v2.2 (http://omics.pnl.gov/software/) 
[113, 192].  Additional analysis was performed using R v2.12.1 (http://www.r-
project.org/).   
 
5.3 Results  
5.3a Mass distribution of interpreted tandem mass spectra and uniqueness statistics 
 The frequency distribution of the masses for the previously identified peptides 
were analyzed (Figure 5.1).  The  frequency distribution of masses of the theoretical 
digests of the BBMV database produced peptides ranging from  400 Da to 6000 Da with 
a median mass of 1320 Da for a total of 40878 theoretical peptides produced from 298 
proteins.  For the observed peptides, the peptides ranged in mass from 723 Da to 3336 Da  
with a median mass of 1512 Da for a total of 1165 peptides from the same 298 proteins.  
The differences in the frequency distributions for the observed and theoretical peptides 
significantly altered the uniqueness statistics for the predictably produced and the 
experimentaly detected peptides  (Figure 5.2).  For the theoretical database, using an 
NRT error of 5%, a  < 5ppm error for the AMT matching was required to ensure the 
peptide match was 80% unique.  For the observed peptides, the least unique measurement 
was ~85% for the median mass of 1512 Da when the constraints were 5% NRT and 20 
ppm error.  The  distribution of mass errors of precursor ions were < ±10ppm error (not  
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Figure 5.1  Effect of tryptic peptide distribution on uniqueness statistics. A) Histogram of 
the density distribution for the peptides identified using tandem mass spectrometry.  The 
frequency distribution of monoisotopic masses represent those mass ranges of peptides 
produced using the conditions for sample preparation and digestion as outlined in Chapter 
IV. The blue line represents the density of the identified peptides from the BBMV 
dataset. The red line indicates the distribution of masses for a theoretical digest of the 
BBMV subset protein database and every possible peptide between 400 - 6000 Da.  B) 
Percent uniqueness statistics using the peptides plotted in A.  Calculation of percent 
unique peptides for a given mass were calculated for every 100 Da between 400 and 6000 
Da for both the real and theoretical datasets. Uniqueness scores are based on the SLiC 
score (P > 0.95)  implemented in the Protein Digestion Parser from PNNL. Calculations 
were based on 5% normalized retention time (NRT) error and for 20, 10, and 5ppm mass 
error. 
  
 
Figure 5.1
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Figure 5.2 Mass versus retention time plots.  A) Masses and predicted retention times for 
the theoretical digest of peptides from the proteins identified in Chapter IV were plotted.  
The results indicated a dense distribution of peptides that would be difficult to identify 
using the AMT approach. B) Distribution of experimentally produced peptides from 
Chapter IV.  Since not all theoretical peptides for a sample are detected during a typical 
MS experiment, the identified peptides yield a set that are more amenable to AMT 
analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 
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shown).  Taken together, the results indicated that the mass error for assignment of 
precursor ions in the SpC study was sufficient for AMT identification of LC-MS peptide 
features. 
 
5.3b Development of the AMT database and matching to LC-MS features 
 The assembled AMT database was filtered for the highest quality peptides 
identified during the SpC study. 1331 peptides from 298 proteins were successfully 
included in the AMT database. To ensure that the abundances could be measured 
between the sample categories, the aligned database contained peptides from each group 
which were subsequently filtered for a minimum of  50% of  replicates per sample group.  
The LC-MS runs were subsequently matched to the database  individually and then 
aligned into a peptide array.  This array contained  a total of 483 peptides from 183 
proteins and contained the most reproducible  LC-MS features matched to the AMT 
database.  Reproducibility of retention time is a measure of peptide hydrophobicity and 
adds statistical confidence for a match to the AMT database[113]. To assess the 
reproducibility of elution times for each of the matched and aligned LC-MS runs,  the 
calculated observed hydrophobicities for the aligned peptides were compared to the 
median observed hydrophobicities (Figure 5.3A). Visual inspection of the clustered 
peptides indicated that the observed hydrophobicities were highly reproducible and were 
within 3% error of the entire range of hydrophobicity (NRT) for each peptide identified.  
Additionally, the AMT matches were positively correlated (R
2
=0.87) with the predicted 
NRT values that were calculated using the prediction utility (Figure 5.3B), an algorithm  
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Figure 5.3  Analysis by normalized elution times for the AMT identified and filtered 
peptide features  A) Detail of boxplots of the median observed hydrophobicity versus the 
run observed hydrophobicities for each of the 482 filtered  AMT peptides.  The % 
observed hydrophobicity was less than 3% for all reported peptides as compared between 
samples. Inset that shows the alignment of each peptide to the median observed 
hydrophobicity, colored by injection, was highly correlated.  B) Plot of  calculated 
normalized retention times (NRT) versus the observed hydrophobicities of each peptide 
identified in the aligned AMT database.  NRT values were calculated using the identified 
petide sequences and the Sequence Specific Retention Calculator v3.1 
(http://hs2.proteome.ca/).  Observed hydrophobicities for the ~1200 AMT peptides were 
calculated using the msInspect v2.3 (http://proteomics.fhcrc.org/)  Peptidearray method.  
Red lines indicate the 95% confidence interval.  Linear regression analysis of the 
observed versus theoretical retention times showed a postivie correlation (R
2
 = 0.87). 
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used in msInspect[192].  While several peptides were outside the 95% confidence limits, 
these were not excluded as outliers since the AMT prediction is dependent on both 
observed hydrophobicity and monoisotopic mass. 
 
5.3c  Data normalization 
 In order to determine the true magnitude of the effect on the abundances due to 
MA, the dataset was log 2 adjusted and then normalized using the Lowess method in the 
DanteR software[193]. Diagnostic boxplots indicated that the data was normally  
distributed and normalized (Figure 5.4).  Additional analysis indicated positive 
correlation between all samples (avg R
2
=0.82).  PCA analysis indicated that the samples 
within the categories were most similar (Figure 5.5).  The Control and 7 Day MA 
samples were most dissimilar whereas the 1 and 3 Day MA samples were most similar.  
These results reproduced the general trends in the data observed for the SpC study. 
 
5.3d  Significance analysis for peptide level changes in abundance 
 The significance of the differential changes in abundances of peptides were 
determined. Analysis of variance (ANOVA) was performed using the Control group as 
the reference group (Figure 5.6).  For the 1-d group, there were 108 peptides with an 
increase in abundance  and 95 peptides with a decrease in abundance (p<0.5, Fold change 
> 1.5).  For the 3-d group, the total peptides with a significant increase and decrease in 
abundance were 123 and 87, respectively.  The total peptides with significant changes for 
the 7-d group were 107 and 78, respectively.   
 The overall trends in the dataset indicated that the significant changes in the 1-d, 
3-d, and 7-d acidotic groups versus the controls were similar, but that there were also  
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Figure 5.4 Boxplots of the peptide abundances for each LC-MS injection replicate. The 
log 2 adjusted data was lowes normalized and then filtered for the most reproducible 
peptides across all categories.  Black dots in the plot represent each datapoint (peptide) 
and are normally distributed and open circles represent outlier observations.  Numbers 
indicate total number of peptides per category. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4
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Figure 5.5. Principle components analysis of the peptides identified using AMT.   The 
data grouped similar to the spectral count data in chapter 4.  Each colored point 
represents one technical replicate.  The Control and 7 day MA group groups were most 
unique and the 1 and 3 day MA samples were most similar.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5
 
 
 
 
 
 
134
 
 135
 
 
 
Figure 5.6  Peptide level volcano plots of log 2 fold change of abundance versus pvalue.  
The significance of peptide abundances for each condition as compared to the control 
group was determined and plotted versus the fold changes.  Blue dots indicate data which 
was significant for the Control versus 1-d MA group (ANOVA, p < 0.05). Vertical dash 
lines indicate 1.5 fold change and horizontal  dashed lines indicate the p value cutoff. 
 
Figure 5.6
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significant changes in the 3-d and 7-d groups that were not detected during the 1-d vs 
Control comparison.   The individual trends for the peptides for a  selected marker 
identified during the SpC study were analyzed (Figure 5.7).  For FBP1, an important 
enzyme of gluconeogenesis and the response to MA, the individual trends for the 5 
identified peptides were similarly decreased during MA.  These analysis indicated 
changes at the peptide level that were similar to the protein level analysis using SpC. 
 
5.3e  Significance analysis for protein level changes in abundance 
 Since trends in the data were similar to those for select markers identified during 
the SpC analysis, significance of those changes at the protein level were determined.    
Again, using ANOVA (p<0.05, Fold change > 1.5), several significant changes were 
noted (Table 1).  For the 1-d group, there were 16 proteins whose abundances were 
increased  and 17 proteins whose abundances were decreased.  For the 3-d group, the 
total proteins with a significant increase and decrease in abundance were 22 and 15, 
respectively.  The total concordant significant changes for the 7 Day group were 16 and 
14, respectively.  Of interest were those proteins identified during the SpC study that are 
known enzymes of glycolysis and gluconeogenesis in addition to other markers (Figure 
5.8).  Of these, FBP1 (F16P1) , enolase (ENOA), and aldolase (Q66HT1) were 
significantly decreased during 1,3, and 7 days MA.  In addition, the SGLT2 (SC5A2) 
transporter significantly increased during 3 Day chronic metabolic acidosis, although was 
not detected for a significant change during 1 day chronic metabolic acidosis as in the 
SpC study.  The Na
+
 dependent phosphate tranporter 2 was significantly increased during 
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Figure 5.7 . Peptide level abundance analysis of fructose-1,6- bisphosphatase -1 (F16P1). 
Top panel shows the log 2 abundances for individual peptides identified by AMT 
decreasing through 7 Days acidosis.  Bottom panels represent two of the peptides 
identified in the spectral counting study and which were used to build the AMT database. 
 
Figure 5.7 
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Figure 5.8  Log fold changes of selected markers identified using AMT.   Aquaporin 1 
(Aquaporin 1), Gamma glutamyl transpeptidase (GGT1), B
0
AT1 transporter (S6A19),  
Na
+
 facilitated glucose transporter SGLT2 (SC5A2),  glyceraldehyde-3-phophate 
dehydrogenase (Glyceraldehyde-3-phophate dehydrogenase), enolase a (ENOA), 
fructose-1,6-bis-phosphatase 1 (F16P1), aldolase a (ALDO_A).  
 
 
 
 
 
 
Figure 5.8
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3 and 7 days MA.  Additionally, the Na
+
 dependent neutral amino acid transporter B
0
AT1 
(S6A19) was significantly increased during 1 and 3 days MA. 
 
5.3f  Comparison of measurements of abundance by LC-MS versus SpC of selected 
markers.  
 To show correlation between the LC-MS and SpC methods, selected markers 
were compared (Figure 5.9).  These markers, including γ-glutamyltranspeptidase, 
SC5A2, TMM27, ENOA, Glyceraldehyde-3-phophate dehydrogenase and F16P1, 
exhibited similar trends for their changes in abundance. The log 2 fold changes where 
overestimated for some of the changes that were determined using the SpC method.  
Generally, there were increases or decreases in abundance detected by both  LC-MS and 
SpC.   
 
5.3g  Western blot data of SC5A2 and GLUT2 changes during MA. 
 SGLT2 is an apical specific marker of the PCT[43].  Likewise, the renal 
facilitated glucose tranporter (GLUT2) is specific to the basolateral surface of the 
PCT[194, 195]. The detected changes by LC-MS during MA indicated that SGLT2  
increased during 1-d MA, and  then significantly increased during 3 Day MA.  These 
results were similar to the SGLT2 data from the SpC study.  Since SGLT2 is involved in 
glucose influx and GLUT2 is involved in glucose efflux from the PCT, we performed 
Glut2 and SGLT2 immunoblots on cortical homogenate (Figure 5.10).   The results 
indicated an increase in the expression of SGLT2 during 1 and 3 days MA, similar to the 
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Figure 5.9. Correlation of log 2 fold changes for selected markers using SpC versus 
AMT. The log 2 fold change of LC-MS peak intensities for the selected markers from 
Table5.1 were compared to the dataset produced in Chapter IV.  Proteins with an increase 
in abundance are shown in red. Proteins with a decrease in abundance are shown in 
green.   The data positively correlated SpC abundance measurements with those garnered 
from peak intensity. dataset in Chapter IV.  This indicated that there was correlation 
between abundance measurements using SpC with those using peak intensities. 
 
Figure 5.9
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Figure 5.10  Immunoblot analysis of SGLT2 and Glut2 expression.  20ug of cortical 
homogenate was probed for PCT specific markers SGLT2 and GLUT2 expression.  
SGLT2 exhibited significant increases during 1-d and 3-d (p<0.01, T test, FC>7.0) and 7 
day (p<0.05 (FC >3.0) ) MA.   Glut2, a basolateral marker ony exhibited a slight increase 
during 7-d MA.   Coomassie stained samples are shown to indicate equivalent loading. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10
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LC-MS and SpC results. Similarly, GLUT2 expression increased for the same timepoints, 
but maintained it's increased expression during 7 day MA.   
 
5.4 Discussion  
 Using AMT identification and the more accurate abundance profiling by LC-MS, 
our results positively correlate with those from the SpC study in chapter4.  In addition, 
the identification of peptides using AMT and data acquired on a QTOF instrument is a 
novel concept.  While AMT with the QTOF is commonly used for metabolite and small  
molecule research, there have been few published reports using this approach for 
proteomics.  Two previous studies using msInspect have been completed [196, 197]. 
However, both of these studies utilized a targeted MS/MS approach after identification of 
those peptide features with altered abundances.   Due to our reduced sample complexity  
through enrichment of the BBMV, we have been able to take advantage of the short 
protein list and the predictable activity of trypsin.  There could be potential unidentified 
peptides from the samples missed in AMT, but the similar protein lists from both the 
fractionated SpC (Chapter III) and the altered dynamic data acquisition mode SpC 
(Chapter IV) and  AMT studies produced similar identifications.  In addition, the main 
proteins of interest such as those involved in glucose metabolism, SGLT2, TMM27, 
among others were identified in the mixture by AMT.  
 
  
 
 
 
 
TABLE 5.1
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CHAPTER 6 
Conclusions and Future Directions 
 
6.1 Overview 
The nephron is a complex structure whose distribution of cell types impart distinct 
cellular and physiological functions.  The earliest part of the nephron, the proximal 
convoluted tubule (PCT), is the primary location for solute and water reabsorption, active 
secretion, the maintenance of acid-base balance and the restoration of physiological pH 
during metabolic acidosis.  At the apical brush border membrane the response during MA 
promotes the remodeling of proteins such as γ-glutamyltranspeptidase, NHE3, and B
0
AT-
1 that are key to the cell's response to increased glutamine catabolism.  Despite our 
current knowledge of this response, little is known about the concurrent changes which 
occur at the membrane following the onset of MA.  To assess these changes, we 
performed three distinct proteomic analysis. 
In chapter 3, we described the first characterization of brush border membrane 
vesicles (BBMV) specifically from the PCT (BBMVPCT).  A well established method by 
Biber et. al[80],  has been suggested to specifically enrich BBMV from the PCT.  
Additionally, using this method, a previous proteomic analysis by Cutillas et. al[82] was 
completed that profiled the inventory of proteins for BBMVCTX.  However, our analysis 
by Western blot demonstrated that the method of Biber enriches not only BBMVPCT, but 
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also apical membranes from the proximal straight tubule and other cells along the 
nephron. This demonstrated that the method used to enrich BBMVCTX were subject to 
issues arising from sample heterogeneity. Due to this effect, we enriched BBMV from 
isolated PCT for our subsequent analysis.  Using spectral counting as a measure of 
abundance, the comparative proteomic analysis for BBMVPCT  versus BBMVCTX 
demonstrated several quantitative differences.  These differences included enzymes of 
glucose metabolism that were enriched in the BBMVPCT samples. The presence of this 
group of proteins were in agreement with the current knowledge PCT cell function.  
Because of this, it was hypothesized that due to the role of gluconeogenesis in glutamine 
catabolism together with the PCT role in glucose reabsorbtion, altered abundances of 
these proteins such as fructose-1,6-bisphosphatase 1 (FBP1) would occur during onset of 
acidosis. 
For the second proteomic analysis, the effect of MA on the BBMVPCT supported 
the hypothesis for the remodeling of the enzymes of glycolysis at the apical membrane.   
Again, using spectral counting, the relative changes in abundance during 1-d, 3-d, and 7-
d MA were studied.  Several proteins were found to be differentially altered in 
abundance, whereas others were found to increase or decrease during acute acidosis (1-d 
and 3-d) but return to control levels by 7-d of acidosis. It was determined that FBP1 and 
ENO1 both decreased during 1-d , 3-d, and 7-d acidosis, whereas aldolase decreased and 
then returned to basal levels at 7-d.   Interestingly, SGLT2 increased during 1-d and 3-d 
of MA, then returned to near basal levels at 7-d MA.  Spectral counting for the detection 
of changes in relative abundance has proven to be more accurate as the counts per protein 
increase.  We noted several changes for proteins with larger spectral counts that were 
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significantly altered.  These included SGLT2, the previous mentioned enzymes of 
glycolysis, as well as  additional proteins involved in cystoskeletal transport (Myosin VI)  
and peptidase activity (MGAM).  Since spectral counting is only a semi-quantitative 
estimate of abundance changes, more accurate LC-MS analysis was completed. 
For this third proteomic analysis, a novel approach to accurate mass and time tag 
analysis was completed using the QTOF mass spectrometer. To accomplish this, we 
prepared a sample of reduced complexity from a distinct portion of the cell.  For this 
study, it was important establish the reproducibility of the peptide lists from the previous 
spectral counting analysis together with the mass accuracy of the instrument.   These two 
parameters combined with the micro scale HPLC C18 chip to serve as a robust platform 
for highly reproducible reversed phase HPLC - high mass accuracy mass spectrometry.   
The measured elution times for the eluted peptides for the 24 separate injections were 
highly reproducible. Clustering of these retention time values indicated an error of < 
3.0% of the total retention time range.   This, together with the  < 5 ppm mass error 
produced during the spectral counting study on the same instrument enabled 
identification of the peptide sequences.  Some of these identities were validated by testing 
for the concordant abundance changes between the SpC method and the LC-MS methods 
which used peak intensities as the abundance measurement.  This AMT approach is 
promising for those with limited access to instrumentation if the sample complexity can 
be reduced, as is the case for subcellular proteomics.  Additionally, if the reproducibility 
of obtaining the expected tryptic peptides can be established, then the robustness of the 
AMT approach will increase. 
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6.2  SGLT2., GLUT2, ENOA  and FBP1  altered abundances during metabolic 
acidosis 
 During acute (1-d) metabolic acidosis, SGLT2 expression increases, followed by 
a further increase during 3-d MA, then subsequently decreases to near basal levels during 
7-d MA.  Since SGLT2 is responsible for the recovery of glucose from the lumen[43], we 
tested expression of the basolateral glucose transporter 2 (GLUT2).  GLUT2 expression 
remained relatively unchanged during MA, only increasing slightly at 7-d acidosis.   It is 
possible that the high capacity GLUT2 transporter efficiently compensates for the 
increased recovery of glucose from the lumen.  Glucose concentration in the urine is 
affected by the onset of MA,  hence, the increased SGLT2 expression could account for  
increased renal extraction of glucose in the PCT during MA.    
 Fructose-1,6-bisphosphatase in the BBMVPCT decreases significantly during 1-d, 
3-d, and 7-d MA.   In the nephron, FBP1 is most abundant in the early parts of the PCT 
and is required for gluconeogensis during MA[29].   During acidosis, the decrease in 
FBP1 at the membrane may indicate a shift in localization of FBP1 to aid in the increase 
of gluconeogensis.  Enolase 1 (ENOA), likewise is decreased at the apical surface. 
ENOA is responsible for the reversible catalysis of the conversion between 2-
phosphoglycerate and phophsoenolpyruvate.  As such, ENOA altered distribution  may 
be supporting gluconeogenesis and the conversion of phophsoenolpyruvate from PEPCK 
to 2-phosphoglycerate to for subsequent steps in the gluconeogenic pathway during MA.  
These results suggest a model for enzyme translocation, suggest the movement of a 
glycolytic complex from the apical surface to the cytosol during MA (Figure 6.1). 
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Figure 6.1 Model for internalization of FBP1 and ENOA.  During normal acid-base, 
many enzymes of glucose metabolism including FBP1 and ENOA are present at the 
apical surface.  During MA, the enzymes decrease at the surface, and may aid in 
metabolism of GLN to produce glucose.  SGLT2 increases probably to increase the 
reabsorption of glucose in the PCT, which GLUT2 facilitates it’s release to the blood.  
Red indicates an increase in the protein abundance or molecule concentration.  Light red 
indicates a slight increase.  Red arrow indicates an increased flux from GLN to glucose 
production.  Green indicates a decrease during acidosis. 
 
 
 
 
 
 
 
 
 
 
Figure 6.1
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6.3 Future directions 
 Proteomic studies attempt to elucidate the global changes in proteins that occur 
during adaptations to physiological and pathological conditions.  In other cases, they 
attempt to provide a 'snap-shot' inventory of the global complement of proteins.  In our 
case, our  snapshot inventory of a comparative analysis led to our testing and validation 
of our hypothesis using temporal and AMT studies.  Subsequent analysis is required to 
validate the model.   Multiple methods for validation exist and include traditional 
methods such as western blotting and immunofluorescence microscopy.  The 
disadvantage to western blot is the lack of information about localization, therefore 
favoring the immuno-fluorescent technique.  This approach would utilize kidney cortex 
slices and would enable the visualization of localization within the cell. Additionally, 
such an approach could help to visualize the distribution along the nephron and may 
indicate specific differences that occur between the proximal convoluted and the 
proximal straight tubule.  
 Another traditional approach could elucidate the specific interactions of the 
glycolytic complex during MA by affinity interaction studies.  Fructose-1,6-
bisphosphatase and aldolase are known to accumulate at the brush border.  Therefore, this 
experimental route may help to elucidate the specific mechanisms by which protein-
protein interactions are modulated within the PCT cell to meet its need to catabolize 
GLN.  Specifically co-immunoprecipitation or pull-down experiments might reveal 
whether components of the glycolytic complex interact selectively with other enzymes.  
Selective sequence substitution or deletion constructs based on rigorous bioinformatic 
analysis could then be used to test these proposed interactions.  A test for specificity to 
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the BBMV would include probing for interactions specific to the V-H
+
-ATPase and 
aldolase complex, a well documented interaction.   
 To more accurately validate the changes in abundance that occur for the chosen 
targets, a targeted MS approach could be utilized.  For the work we presented in this 
thesis, we chose to match LC-MS features that contain intensity information using AMT 
technology.  This approach is more robust than spectral counting and is advantageous due 
to the sensitivity of detection of the lower abundance of molecules in the mixture.  
However, one limitation for our approach was the sequence validation of the peptide 
molecule that was assayed.   In addition, confirmation of the AMT matching could be 
completed by selective and multiple reaction monitoring of the peptides of interest.  This 
approach commonly uses the triple quadrupole mass spectrometer (QQQ).  This 
instrument combines more accurate quantitation of selected precursor ions followed by 
sequence verification of the same set of precursor ions during the same sample run.  This 
technique increases the specificity for detection of the selected precursor ions. A 
limitation of this technique is the number of targeted transitions that can be acquired 
during a sample injection.  These are limited due to instrument cycling times together 
with sample complexity.  The study described in Chapter V revealed several proteins that 
were altered in abundance, and that were not part of the list of enzymes of glycolysis.  As 
such, the shotgun approach for both spectral counting and LC-MS by AMT matching 
provided the best combination of identification together with robust quantification of 
abundance changes for a list of proteins that will be of interest to those in the field.  
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6.4 Conclusion 
      A thorough proteomic analysis of the changes that occur at the proximal convoluted 
tubule brush border during MA was completed.  These experiments utilized a mixture of 
spectral counting and LC-MS to identify and quantify novel proteins which may be 
important to the tubular response to acidosis.  These changes profiled at the brush border 
included those involved in glucose metabolism.  Such findings are novel but not 
unexpected due to the central role of glucose synthesis that occurs during metabolic 
acidosis.  Further validation of the localization of these events is required to more 
comprehensively understand these changes.  Finally, the completed proteomic analysis 
still serves as a robust method for identification and measurement of the relative changes 
in abundance of these identified proteins in response to other physiological and 
pathological conditions. 
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